Section 10

EurekaMag Full Text Articles Chapter 9,088


Lutz, C.M.; Richards, J.E.; Scott, K.L.; Sinha, S.; Yang-Feng, T.L.; Frankel, W.N.; Thompson, D.A. 1997: Neuropeptide y receptor genes mapped in human and mouse: receptors with high affinity for pancreatic polypeptide are not clustered with receptors specific for neuropeptide y and peptide YY. Genomics 46(2): 287-290
Frankish, H.M.; McCarthy, H.D.; Dryden, S.; Kilpatrick, A.; Williams, G. 1993: Neuropeptide Y receptor numbers are reduced in the hypothalamus of streptozotocin-diabetic and food-deprived rats: further evidence of increased activity of hypothalamic NPY-containing pathways. Peptides 14(5): 941-948
Wan, C.P.; Lau, B.H. 1995: Neuropeptide Y receptor subtypes. Life Sciences 56(13): 1055-1064
Noll, T.; Hempel, A.; Piper, H.M. 1996: Neuropeptide y reduces macromolecule permeability of coronary endothelial monolayers. American Journal of Physiology 271(5 Part 2): H1878-H1883
Ohtomo, Y.; Ono, S.; Zettergren, E.; Sahlgren, B. 1996: Neuropeptide y regulates rat renal tubular Na,K-ATPase through several signalling pathways. Acta Physiologica Scandinavica 158(1): 97-105
Contijoch, A.M.; Malamed, S.; McDonald, J.K.; Advis, J.P. 1993: Neuropeptide Y regulation of LHRH release in the median eminence: immunocytochemical and physiological evidence in hens. Neuroendocrinology 57(1): 135-145
Hunter, L.W.; Tyce, G.M.; Rorie, D.K. 1996: Neuropeptide Y release and contractile properties: Differences between canine veins and arteries. European Journal of Pharmacology 313(1-2): 79-87
Gemignani, A.; Marchese, S.; Fontana, G.; Raiteri, M. 1997: Neuropeptide Y release from cultured hippocampal neurons: Stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors. Neuroscience 81(1): 23-31
Kaijser, L.; Pernow, J.; Berglund, B.; Grubbström, J.; Lundberg, J.M. 1994: Neuropeptide Y release from human heart is enhanced during prolonged exercise in hypoxia. Journal of Applied Physiology 76(3): 1346-1349
Sahu, A.; Sninsky, C.A.; Phelps, C.P.; Dube, M.G.; Kalra, P.S.; Kalra, S.P. 1992: Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. Endocrinology 131(6): 2979-2985
Beck, B.; Kozak, R.; Stricker-Krongrad, A.; Burlet, C. 1998: Neuropeptide y release in the paraventricular nucleus of Long-Evans rats treated with leptin. Biochemical and Biophysical Research Communications 242(3): 636-639
Yamada, K.; Shibasaki, T.; Tsumori, C.; Imaki, T.; Hotta, M.; Wakabayashi, I.; Demura, H. 1996: Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats. Brain Research 725(2): 272-275
Waeber, G.; Hurlimann, J.; Haefliger, J.A.; Gomez, F.; Nicod, P.; Grouzmann, E. 1996: Neuropeptide y secretion from a human insulinoma. Journal of Endocrinological Investigation 19(3): 190-195
Kuvshinoff, B.W.; Nussbaum, M.S.; Richards, A.I.; Bloustein, P.; Mcfadden, D.W. 1992: Neuropeptide Y secretion from a malignant extraadrenal retroperitoneal paraganglioma. Cancer 70(9): 2350-2353
Holtbäck, U.; Ohtomo, Y.; Förberg, P.; Sahlgren, B.; Aperia, A. 1998: Neuropeptide y shifts equilibrium between alpha- and beta-adrenergic tonus in proximal tubule cells. American Journal of Physiology 275(1): F1-F7
Shigeri, Y.; Fujimoto, M. 1993: Neuropeptide Y stimulates DNA synthesis in vascular smooth muscle cells. Neuroscience Letters 149(1): 19-22
Kalra, P.S.; Norlin, M.; Kalra, S.P. 1995: Neuropeptide y stimulates beta-endorphin release in the basal hypothalamus: role of gonadal steroids. Brain Research 705(1-2): 353-356
Yoneda, M.; Nakamura, K.; Yokohama, S.; Tamori, K.; Sato, Y.; Aso, K.; Aoshima, M.; Kono, T.; Makino, I. 1998: Neuropeptide y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats. Hepatology 28(3): 670-676
Millar, B.C.; Schlüter, K.D.; Zhou, X.J.; McDermott, B.J.; Piper, H.M. 1994: Neuropeptide y stimulates hypertrophy of adult ventricular cardiomyocytes. American Journal of Physiology 266(5 Part 1): C1271-C1277
Erlinge, D.; Brunkwall, J.; Edvinsson, L. 1994: Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regulatory Peptides 50(3): 259-265
Klapstein, G.J.; Colmers, W.F. 1997: Neuropeptide y suppresses epileptiform activity in rat hippocampus in vitro. Journal of Neurophysiology 78(3): 1651-1661
Wang, J.; Ciofi, P.; Crowley, W.R. 1996: Neuropeptide y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry. Endocrinology 137(2): 587-594
Grundemar, L.; Wahlestedt, C.; Wang, Z.Y. 1993: Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action. Regulatory Peptides 43(1-2): 57-64
Thind, K.K.; Boggan, J.E.; Goldsmith, P.C. 1993: Neuropeptide Y system of the female monkey hypothalamus: retrograde tracing and immunostaining. Neuroendocrinology 57(2): 289-298
Sheriff, S.; Chance, W.T.; Fischer, J.E.; Balasubramaniam, A. 1997: Neuropeptide y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus. Molecular Pharmacology 51(4): 597-604
Norström, A.; Bryman, I.; Dahlström, A. 1992: Neuropeptide Y, its localization in the human cervix and possible effect on the contractile activity of cervix smooth muscle. Gynecologic and Obstetric Investigation 34(3): 175-179
Mathé, A.A.; Jimenez, P.A.; Theodorsson, E.; Stenfors, C. 1998: Neuropeptide Y, neurokinin A and neurotensin in brain regions of Fawn Hooded "depressed", Wistar, and Sprague Dawley rats. Effects of electroconvulsive stimuli. Progress in Neuro-Psychopharmacology and Biological Psychiatry 22(3): 529-546
Ullman, B.; Jensen-Urstad, M.; Hulting, J.; Lundberg, J.M. 1993: Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure. Clinical Physiology 13(4): 409-418
Cummings, S.L. 1997: Neuropeptide Y, somatostatin, and cholecystokinin of the anterior piriform cortex. Cell and Tissue Research 289(1): 39-51
Frankish, H.M.; Dryden, S.; Hopkins, D.; Wang, Q.; Williams, G. 1995: Neuropeptide Y, the Hypothalamus, and Diabetes: Insights Into the Central Control of Metabolism. Peptides 16(4): 757-771
Tomaszuk, A.; Simpson, C.; Williams, G. 1996: Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Hormone Research 46(2): 53-58
Ahmed, M.; Bjurholm, A.; Kreicbergs, A.; Schultzberg, M. 1993: Neuropeptide Y, tyrosine hydroxylase and vasoactive intestinal polypeptide-immunoreactive nerve fibers in the vertebral bodies, discs, dura mater, and spinal ligaments of the rat lumbar spine. Spine 18(2): 268-273
McQuiston, A.R.; Petrozzino, J.J.; Connor, J.A.; Colmers, W.F. 1996: Neuropeptide Y1 receptors inhibit N-type calcium currents and reduce transient calcium increases in rat dentate granule cells. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(4): 1422-1429
Krause, J.; Eva, C.; Seeburg, P.H.; Sprengel, R. 1992: Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Molecular Pharmacology 41(5): 817-821
Lemos, V.S.; Takeda, K. 1995: Neuropeptide Y2-type receptor-mediated activation of large-conductance Ca(2+)-sensitive K+ channels in a human neuroblastoma cell line. Pflugers Archiv: European Journal of Physiology 430(4): 534-540
Westfall, T.C.; Yang, C.L.; Rotto-Perceley, D.; Macarthur, H. 1996: Neuropeptide Y-ATP interactions and release at the vascular neuroeffector junction. Journal of Autonomic Pharmacology 16(6): 345-348
Bischoff, A.; Erdbrügger, W.; Smits, J.; Michel, M.C. 1996: Neuropeptide Y-enhanced diuresis and natriuresis in anaesthetized rats is independent of renal blood flow reduction. Journal of Physiology 495: 525-534
Sosunov, A.A.; Hassall, C.J.; Loesch, A.; Turmaine, M.; Fehér, E.; Burnstock, G. 1997: Neuropeptide Y-immunoreactive intracardiac neurones, granule-containing cells and nerves associated with ganglia and blood vessels in rat and guinea-pig heart. Cell and Tissue Research 289(3): 445-454
Straznicky, C.; Hiscock, J. 1994: Neuropeptide Y-immunoreactive neurons in the retina of two Australian lizards. Archives of Histology and Cytology 57(2): 151-160
Wakisaka, S.; Youn, S.H.; Kato, J.; Takemura, M.; Kurisu, K. 1996: Neuropeptide Y-immunoreactive primary afferents in the dental pulp and periodontal ligament following nerve injury to the inferior alveolar nerve in the rat. Brain Research 712(1): 11-18
Chiba, A.; Honma, Y. 1994: Neuropeptide Y-immunoreactive structures in the telencephalon and diencephalon of the white sturgeon, Acipenser transmontanus, with special regard to the hypothalamo-hypophyseal system. Archives of Histology and Cytology 57(1): 77-86
Doyle, C.A.; Maxwell, D.J. 1993: Neuropeptide Y-immunoreactive terminals form axo-axonic synaptic arrangements in the substantia gelatinosa (lamina II) of the cat spinal dorsal horn. Brain Research 603(1): 157-161
Vila, E.; Reid, J.L.; Macrae, I.M. 1993: Neuropeptide Y-induced inositol phospholipid hydrolysis in blood vessels from normotensive and spontaneously hypertensive rats. General Pharmacology 24(1): 247-251
Wakisaka, S.; Youn, S.H.; Maeda, T.; Kurisu, K. 1996: Neuropeptide Y-like immunoreactive primary afferents in the periodontal tissues following dental injury in the rat. Regulatory Peptides 63(2-3): 163-169
Erlinge, D.; Ekman, R.; Thulin, T.; Edvinsson, L. 1992: Neuropeptide Y-like immunoreactivity and hypertension. Journal of Hypertension 10(10): 1221-1225
Mori, S. 1996: Neuropeptide Y-like immunoreactivity in area 17 of chimpanzee. Okajimas Folia Anatomica Japonica 73(5): 219-227
Grimes, P.A.; Koeberlein, B.; Tigges, M.; Stone, R.A. 1998: Neuropeptide Y-like immunoreactivity localizes to preganglionic axon terminals in the rhesus monkey ciliary ganglion. IOVS Investigative Ophthalmology and Visual Science 39(2): 227-232
Williams, C.A. 1996: Neuropeptide Y-like substances are released from the rostral brainstem of cats during the muscle pressor response. Journal of Physiology 495: 267-277
Van den Pol, A.N.; Obrietan, K.; Chen, G.; Belousov, A.B. 1996: Neuropeptide Y-mediated long-term depression of excitatory activity in suprachiasmatic nucleus neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 16(18): 5883-5895
Kennedy, B.; Shen, G.H.; Ziegler, M.G. 1997: Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system. Journal of Pharmacology and Experimental Therapeutics 281(1): 291-296
Alonso, G.; Privat, A. 1993: Neuropeptide Y-producing neurons of the arcuate nucleus regenerate axons after surgical deafferentation of the mediobasal hypothalamus. Journal of Neuroscience Research 34(5): 510-522
Allen, C.J.; Ghilardi, J.R.; Vigna, S.R.; Mannon, P.J.; Taylor, I.L.; Mcvey, D.C.; Maggio, J.E.; Mantyh, P.W. 1993: Neuropeptide Y/peptide YY receptor binding sites in the heart: Localization and pharmacological characterization. Neuroscience 53(3): 889-898
Kopp, J.; Zhang, X.; Hökfelt, T. 1997: Neuropeptide Y1 receptors in the rat genital tract. Regulatory Peptides 70(2-3): 149-160
White, J.D. 1993: Neuropeptide Y: a central regulator of energy homeostasis. Regulatory Peptides 49(2): 93-107
Zukowska-Grojec, Z.; Karwatowska-Prokopczuk, E.; Rose, W.; Rone, J.; Movafagh, S.; Ji, H.; Yeh, Y.; Chen, W.T.; Kleinman, H.K.; Grouzmann, E.; Grant, D.S. 1998: Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium. Circulation Research 83(2): 187-195
Michel, M.C.; Rascher, W. 1995: Neuropeptide Y: a possible role in hypertension?. Journal of Hypertension 13(4): 385-395
Reuss, S.; Olcese, J. 1995: Neuropeptide Y: distribution of immunoreactivity and quantitative analysis in diencephalic structures and cerebral cortex of dwarf hamsters under different photoperiods. Neuroendocrinology 61(4): 337-347
Moore, E.; Merali, Z.; Beninger, R.J. 1994: Neuropeptide Y: intrastriatal injections produce contralateral circling that is blocked by a dopamine antagonist in rats. Pharmacology Biochemistry and Behavior 48(3): 681-688
D'Aniello, B.; Vallarino, M.; Pinelli, C.; Fiorentino, M.; Rastogi, R.K. 1996: Neuropeptide Y: Localization in the brain and pituitary of the developing frog (Rana esculenta). Cell and Tissue Research 285(2): 253-259
Nakagawara, M.; Sato, Y. 1994: Neuropeptide Y: psychopharmacological and clinical aspects. Nihon Shinkei Seishin Yakurigaku Zasshi 14(3): 117-127
Kirby, D.A.; Boublik, J.H.; Rivier, J.E. 1993: Neuropeptide Y: Y1 and Y2 affinities of the complete series of analogues with single D-residue substitutions. Journal of Medicinal Chemistry 36(24): 3802-3808
Josselyn, S.A.; Beninger, R.J. 1993: Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacology Biochemistry and Behavior 46(3): 543-552
Connor, M.; Yeo, A.; Henderson, G. 1997: Neuropeptide YY-2 receptor and somatostatin sst-2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. British Journal of Pharmacology 120(3): 455-463
Shigeri, Y.; Nakajima, S.; Fujimoto, M. 1995: Neuropeptide YY1 receptors-mediated increase in intracellular Ca2+ concentration via phospholipase C-dependent pathway in porcine aortic smooth muscle cells. Journal of Biochemistry 118(3): 515-520
Kaye, W.H. 1996: Neuropeptide abnormalities in anorexia nervosa. Psychiatry Research 62(1): 65-74
Kolhekar, A.S.; Roberts, M.S.; Jiang, N.; Johnson, R.C.; Mains, R.E.; Eipper, B.A.; Taghert, P.H. 1997: Neuropeptide amidation in Drosophila: separate genes encode the two enzymes catalyzing amidation. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(4): 1363-1376
Al'Abadie, M.S.; Senior, H.J.; Bleehen, S.S.; Gawkrodger, D.J. 1994: Neuropeptide and neuronal marker studies in vitiligo. British Journal of Dermatology 131(2): 160-165
Cheung, R.T.; Cechetto, D.F. 1995: Neuropeptide changes following excitotoxic lesion of the insular cortex in rats. Journal of Comparative Neurology 362(4): 535-550
Cornefjord, M.; Olmarker, K.; Farley, D.B.; Weinstein, J.N.; Rydevik, B. 1995: Neuropeptide changes in compressed spinal nerve roots. Spine 20(6): 670-673
Valenti, G. 1996: Neuropeptide changes in dementia: pathogenetic implications and diagnostic value. Gerontology 42(5): 241-256
Levin, M.C.; Sawchenko, P.E. 1993: Neuropeptide co-expression in the magnocellular neurosecretory system of the female rat: Evidence for differential modulation by estrogen. Neuroscience 54(4): 1001-1018
Lilly, C.M.; Bai, T.R.; Shore, S.A.; Hall, A.E.; Drazen, J.M. 1995: Neuropeptide content of lungs from asthmatic and nonasthmatic patients. American Journal of Respiratory and Critical Care Medicine 151(2 Part 1): 548-553
El-Salhy, M.; Spångéus, A. 1998: Neuropeptide contents in the duodenum of non-obese diabetic mice. Acta Diabetologica 35(1): 9-12
Holmgren, S. 1995: Neuropeptide control of the cardiovascular system in fish and reptiles. Brazilian Journal of Medical and Biological Research 28(11-12): 1207-1216
Coleman, M.J.; Konstant, P.H.; Rothman, B.S.; Nusbaum, M.P. 1994: Neuropeptide degradation produces functional inactivation in the crustacean nervous system. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(10): 6205-6216
Ustinova, E.E.; Bergren, D.; Schultz, H.D. 1995: Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P. Cardiovascular Research 30(1): 55-63
Jiménez, C.R.; van Veelen, P.A.; Li, K.W.; Wildering, W.C.; Geraerts, W.P.; Tjaden, U.R.; van der Greef, J. 1994: Neuropeptide expression and processing as revealed by direct matrix-assisted laser desorption ionization mass spectrometry of single neurons. Journal of Neurochemistry 62(1): 404-407
Mulderry, P.K. 1994: Neuropeptide expression by newborn and adult rat sensory neurons in culture: Effects of nerve growth factor and other neurotrophic factors. Neuroscience 59(3): 673-688
Hoyle, C.H. 1998: Neuropeptide families: Evolutionary perspectives. Regulatory Peptides 73(1): 1-33
Wang, Y.; Bockman, C.S.; Lovas, S.; Abel, P.W.; Murphy, R.F.; Conlon, J.M. 1993: Neuropeptide gamma-(1-9)-peptide: a major product of the posttranslational processing of gamma-preprotachykinin in rat tissues. Journal of Neurochemistry 61(4): 1231-1235
Polidori, C.; Staffinati, G.; Perfumi, M.C.; de Caro, G.; Massi, M. 1995: Neuropeptide gamma: a mammalian tachykinin endowed with potent antidipsogenic action in rats. Physiology and Behavior 58(3): 595-602
Donaldson, L.F.; McQueen, D.S.; Seckl, J.R. 1995: Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat. Journal of Physiology 486: 473-482
Macarthur, L.; Eiden, L. 1996: Neuropeptide genes: Targets of activity-dependent signal transduction. Peptides 17(4): 721-728
Gammie, S.C.; Truman, J.W. 1997: Neuropeptide hierarchies and the activation of sequential motor behaviors in the hawkmoth, Manduca sexta. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(11): 4389-4397
Karila, P.; Axelsson, M.; Franklin, C.E.; Fritsche, R.; Gibbins, I.L.; Grigg, G.C.; Nilsson, S.; Holmgren, S. 1995: Neuropeptide immunoreactivity and co-existence in cardiovascular nerves and autonomic ganglia of the estuarine crocodile, Crocodylus porosus, and cardiovascular effects of neuropeptides. Regulatory Peptides 58(1-2): 25-39
Long, A.; Bongenhielm, U.; Boissonade, F.M.; Fried, K.; Robinson, P.P. 1998: Neuropeptide immunoreactivity in ligature-induced neuromas of the inferior alveolar nerve in the ferret. Brain Research 791(1-2): 263-270
Ewer, J.; De Vente, J.; Truman, J.W. 1994: Neuropeptide induction of cyclic GMP increases in the insect CNS: resolution at the level of single identifiable neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 14(12): 7704-7712
Fang, S.Y.; Shen, C.L. 1998: Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 28(2): 228-232
Nerlich, M.L.; Holch, M.; Stalp, M.; Dwenger, A.; Fauler, J. 1994: Neuropeptide levels early after trauma: immunomodulatory effects?. Journal of Trauma 37(5): 759-768
Kawada, Y.; Ogawa, N.; Asanuma, M.; Mori, A. 1995: Neuropeptide levels in discrete brain regions in the iminodipropionitrile-induced persistent dyskinesia rat model. Regulatory Peptides 55(1): 103-110
Kawada, Y.; Ogawa, N.; Asanuma, M.; Mori, A. 1994: Neuropeptide levels in discrete brain regions of mice treated with iminodipropionitrile. Neurosciences 20(Suppl ): P41-P44
Cenci, M.A.; Campbell, K.; Björklund, A. 1993: Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels. Neuroscience 57(2): 275-296
Waters, S.M.; Konkoy, C.S.; Davis, T.P. 1995: Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation. Journal of Pharmacology and Experimental Therapeutics 274(2): 783-789
Veronesi, B.; Sailstad, D.M.; Doerfler, D.L.; Selgrade, M. 1995: Neuropeptide modulation of chemically induced skin irritation. Toxicology and Applied Pharmacology 135(2): 258-267
Hisa, Y.; Tadaki, N.; Uno, T.; Okamura, H.; Taguchi, J.; Ibata, Y. 1994: Neuropeptide participation in canine laryngeal sensory innervation. Immunohistochemistry and retrograde labeling. Annals of Otology Rhinology and Laryngology 103(10): 767-770
Kar, S.; Quirion, R. 1995: Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, mu-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors. Journal of Comparative Neurology 354(2): 253-281
Wainwright, G.; Webster, S.G.; Rees, H.H. 1998: Neuropeptide regulation of biosynthesis of the juvenoid, methyl farnesoate, in the edible crab, Cancer pagurus. Biochemical Journal 334: 651-657
Tang, H.; Welton, A.; Ganea, D. 1995: Neuropeptide regulation of cytokine expression: effects of VIP and Ro 25-1553. Journal of Interferon and Cytokine Research: the Official Journal of the International Society for Interferon and Cytokine Research 15(11): 993-1003
Dickerson, C.; Undem, B.; Bullock, B.; Winchurch, R.A. 1998: Neuropeptide regulation of proinflammatory cytokine responses. Journal of Leukocyte Biology 63(5): 602-605
Söderberg, C.; Pieribone, V.A.; Dahlstrand, J.; Brodin, L.; Larhammar, D. 1994: Neuropeptide role of both peptide YY and neuropeptide y in vertebrates suggested by abundant expression of their mRNAs in a cyclostome brain. Journal of Neuroscience Research 37(5): 633-640
Rioli, V.; Kato, A.; Portaro, F.C.; Cury, G.K.; te Kaat, K.; Vincent, B.; Checler, F.; Camargo, A.C.; Glucksman, M.J.; Roberts, J.L.; Hirose, S.; Ferro, E.S. 1998: Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase family: comparison with the related recombinant endopeptidase Biochemical and Biophysical Research Communications 250(1): 5-11
Davies, S.A.; Stewart, E.J.; Huesmann, G.R.; Skaer, N.J.; Maddrell, S.H.; Tublitz, N.J.; Dow, J.A. 1997: Neuropeptide stimulation of the nitric oxide signaling pathway in Drosophila melanogaster Malpighian tubules. American Journal of Physiology 273(2 Pt 2): R823-R827
Minniti, F.; Potoschi, A.; Crisafulli, C. 1994: Neuropeptide, Y-like immunoreactivity in the brain of the elasmobranch fish, etmopterus spinax. European Archives of Biology 105(1-2): 1-6
Huttunen, M.; Harvima, I.T.; Ackermann, L.; Harvima, R.J.; Naukkarinen, A.; Horsmanheimo, M. 1996: Neuropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique. Acta Dermato-Venereologica 76(3): 205-209
Bluet-Pajot, M.T.; Presse, F.; Voko, Z.; Hoeger, C.; Mounier, F.; Epelbaum, J.; Nahon, J.L. 1995: Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. Journal of Neuroendocrinology 7(4): 297-303
Herzog, H.; Selbie, L.A.; Zee, R.Y.; Morris, B.J.; Shine, J. 1993: Neuropeptide-Y Y1 receptor gene polymorphism: cross-sectional analyses in essential hypertension and obesity. Biochemical and Biophysical Research Communications 196(2): 902-906
Peng, C.; Gallin, W.; Peter, R.E.; Blomqvist, A.G.; Larhammar, D. 1994: Neuropeptide-Y gene expression in the goldfish brain: distribution and regulation by ovarian steroids. Endocrinology 134(3): 1095-1103
Lurton, D.; Cavalheiro, E.A. 1997: Neuropeptide-Y immunoreactivity in the pilocarpine model of temporal lobe epilepsy. Experimental Brain Research 116(1): 186-190
Horvath, T.L.; Naftolin, F.; Kalra, S.P.; Leranth, C. 1992: Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 131(5): 2461-2467
Horvath, T.L.; Shanabrough, M.; Naftolin, F.; Leranth, C. 1993: Neuropeptide-Y innervation of estrogen-induced progesterone receptor-containing dopamine cells in the monkey hypothalamus: a triple labeling light and electron microscopic study. Endocrinology 133(1): 405-414
Larsen, P.J.; Jukes, K.E.; Chowdrey, H.S.; Lightman, S.L.; Jessop, D.S. 1994: Neuropeptide-Y potentiates the secretion of vasopressin from the neurointermediate lobe of the rat pituitary gland. Endocrinology 134(4): 1635-1639
Peng, C.; Chang, J.P.; Yu, K.L.; Wong, A.O.; Van Goor, F.; Peter, R.E.; Rivier, J.E. 1993: Neuropeptide-Y stimulates growth hormone and gonadotropin-Ii secretion in the goldfish pituitary: involvement of both presynaptic and pituitary cell actions. Endocrinology 132(4): 1820-1829
Brooks, A.N.; Howe, D.C.; Porter, D.W.; Naylor, A.M. 1994: Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep. Journal of Neuroendocrinology 6(2): 161-166
Westfall, T.C.; Yang, C.L.; Curfman-Falvey, M. 1995: Neuropeptide-Y-ATP interactions at the vascular sympathetic neuroeffector junction. Journal of Cardiovascular Pharmacology 26(5): 682-687
Keast, J.R. 1994: Neuropeptide-containing axon terminals in the male rat major pelvic ganglion are primarily of sacral origin. Journal of the Autonomic Nervous System 47(1-2): 151-158
Matsuda, H.; Kusakabe, T.; Kawakami, T.; Nagahara, T.; Takenaka, T.; Tsukuda, M. 1997: Neuropeptide-containing nerve fibres in the human parotid gland: A semiquantitative analysis using an antibody against protein gene product 9.5. Histochemical Journal 29(7): 539-544
Howarth, P.H.; Springall, D.R.; Redington, A.E.; Djukanovic, R.; Holgate, S.T.; Polak, J.M. 1995: Neuropeptide-containing nerves in endobronchial biopsies from asthmatic and nonasthmatic subjects. American Journal of Respiratory Cell and Molecular Biology 13(3): 288-296
Crowe, R.; Parkhouse, N.; Mcgrouther, D.; Burnstock, G. 1994: Neuropeptide-containing nerves in painful hypertrophic human scar tissue. British Journal of Dermatology 130(4): 444-452
Lindh, C.; Thornwall, M.; Hansen, A.C.; Post, C.; Gordh, T.; Ordeberg, G.; Nyberg, F. 1996: Neuropeptide-converting enzymes in cerebrospinal fluid: activities increased in pain from herniated lumbar dis, but not from coxarthrosis. Acta Orthopaedica Scandinavica 67(2): 189-192
Moga, M.M.; Saper, C.B. 1994: Neuropeptide-immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. Journal of Comparative Neurology 346(1): 137-150
Baghdassarian, D.; de Bessé, N.; Saïdi, B.; Sommé, G.; Lachaise, F. 1996: Neuropeptide-induced inhibition of steroidogenesis in crab molting glands: Involvement of cGMP-dependent protein kinase. General and Comparative Endocrinology 104(1): 41-51
Carucci, J.A.; Auci, D.L.; Herrick, C.A.; Durkin, H.G. 1995: Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. I. Substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vivo and in vitro. Journal of Leukocyte Biology 57(1): 110-115
Carucci, J.A.; Herrick, C.A.; Durkin, H.G. 1994: Neuropeptide-mediated regulation of hapten-specific IgE responses in mice. II. Mechanisms of substance P-mediated isotype-specific suppression of BPO-specific IgE antibody-forming cell responses induced in vitro. Journal of Neuroimmunology 49(1-2): 89-95
Karimian, S.M.; McDougall, J.J.; Ferrell, W.R. 1995: Neuropeptidergic and autonomic control of the vasculature of the rat knee joint revealed by laser Doppler perfusion imaging. Experimental Physiology 80(3): 341-348
Fang, S.Y.; Shen, C.L. 1997: Neuropeptidergic innervation of human nasal mucosa in various pathological conditions. Proceedings of the National Science Council Republic of China. Part B Life Sciences 21(1): 8-12
Negroni, J.; Nevo, E.; Cooper, H.M. 1997: Neuropeptidergic organization of the suprachiasmatic nucleus in the blind mole rat (Spalax ehrenbergi). Brain Research Bulletin 44(5): 633-639
Terenghi, G.; Sundaresan, M.; Moscoso, G.; Polak, J.M. 1993: Neuropeptides and a neuronal marker in cutaneous innervation during human foetal development. Journal of Comparative Neurology 328(4): 595-603
Lydiard, R.B. 1994: Neuropeptides and anxiety: focus on cholecystokinin. Clinical Chemistry 40(2): 315-318
Al'Abadie, M.S.; Senior, H.J.; Bleehen, S.S.; Gawkrodger, D.J. 1995: Neuropeptides and general neuronal marker in psoriasis--an immunohistochemical study. Clinical and Experimental Dermatology 20(5): 384-389
Arnalich, F.; de Miguel, E.; Perez-Ayala, C.; Martinez, M.; Vazquez, J.J.; Gijon-Banos, J.; Hernanz, A. 1994: Neuropeptides and interleukin-6 in human joint inflammation relationship between intraarticular substance P and interleukin-6 concentrations. Neuroscience Letters 170(2): 251-254
Cuadrado, M.I.; Coveñas, R.; Tramu, G. 1993: Neuropeptides and monoamines in the carp (Cyprinus carpio) pretectum: An immunocytochemical study. Tissue and Cell 25(4): 549-561
Cuadrado, M.I.; Coveñas, R.; Tramu, G. 1992: Neuropeptides and monoamines in the torus semicircularis of the carp (Cyprinus carpio). Brain Research Bulletin 29(5): 529-539
Barajon, I.; Bersani, M.; Quartu, M.; Del Fiacco, M.; Cavaletti, G.; Holst, J.J.; Tredici, G. 1996: Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy. Experimental Neurology 138(1): 93-104
Smet, P.J.; Edyvane, K.A.; Jonavicius, J.; Marshall, V.R. 1996: Neuropeptides and neurotransmitter-synthesizing enzymes in intrinsic neurons of the human urinary bladder. Journal of Neurocytology 25(2): 112-124
Bergman, E.; Johnson, H.; Zhang, X.; Hökfelt, T.; Ulfhake, B. 1996: Neuropeptides and neurotrophin receptor mRNAs in primary sensory neurons of aged rats. Journal of Comparative Neurology 375(2): 303-319
Laverdure, A.M.; Carette-Desmoucelles, C.; Breuzet, M.; Descamps, M. 1994: Neuropeptides and related nucleic acid sequences detected in peneid shrimps by immunohistochemistry and molecular hybridizations. Neuroscience 60(2): 569-579
Gustafsson, M.K.; Fagerholm, H.P.; Halton, D.W.; Hanzelová, V.; Maule, A.G.; Reuter, M.; Shaw, C. 1995: Neuropeptides and serotonin in the cestode, Proteocephalus exiguus: an immunocytochemical study. International Journal for Parasitology 25(6): 673-682
Fisher, L.A.; Brown, M.R. 1993: Neuropeptides and the autonomic nervous system. PsychoTherapy and Psychosomatics 60(1): 39-45
Konttinen, Y.; Imai, S.; Suda, A. 1996: Neuropeptides and the puzzle of bone remodeling. State of the art. Acta Orthopaedica Scandinavica 67(6): 632-639
Aebischer, I.; Stämpfli, M.R.; Zürcher, A.; Miescher, S.; Urwyler, A.; Frey, B.; Luger, T.; White, R.R.; Stadler, B.M. 1994: Neuropeptides are potent modulators of human in vitro immunoglobulin e synthesis. European Journal of Immunology 24(8): 1908-1913
Matthew, E. 1993: Neuropeptides in dissociated cell cultures of mammalian spinal cord and dorsal root ganglion. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 11(6): 721-729
Edvinsson, L.; Goadsby, P.J. 1998: Neuropeptides in headache. European Journal of Neurology 5(4): 329-341
Edvinsson, L.; Goadsby, P.J. 1994: Neuropeptides in migraine and cluster headache. Cephalalgia: An International Journal of Headache 14(5): 320-327
Sand, J.; Tainio, H.; Nordback, I. 1993: Neuropeptides in pig sphincter of Oddi, bile duct, gallbladder, and duodenum. Digestive Diseases and Sciences 38(4): 694-700
Espiritu, R.F.; Pittet, J.F.; Matthay, M.A.; Goetzl, E.J. 1992: Neuropeptides in pulmonary edema fluid of adult respiratory distress syndrome. Inflammation 16(5): 509-517
Roy, A. 1993: Neuropeptides in relation to suicidal behavior in depression. Neuropsychobiology 28(4): 184-186
Lotti, T.; Hautmann, G.; Panconesi, E. 1995: Neuropeptides in skin. Journal of the American Academy of Dermatology 33(3): 482-496
Tóth, I.E.; Hinson, J.P. 1995: Neuropeptides in the adrenal gland: Distribution, localization of receptors, and effects on steroid hormone synthesis. Endocrine Research 21(1-2): 39-51
Appelgren, A.; Appelgren, B.; Kopp, S.; Lundeberg, T.; Theodorsson, E. 1995: Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis. Journal of Orofacial Pain 9(3): 215-225
Marcos, P.; Coveñas, R.; Narvaez, J.A.; Aguirre, J.A.; Tramu, G.; Gonzalez-Baron, S. 1998: Neuropeptides in the cat amygdala. Brain Research Bulletin 45(3): 261-268
Edvinsson, L.; Goadsby, P.J. 1995: Neuropeptides in the cerebral circulation: Relevance to headache. Cephalalgia: An International Journal of Headache 15(4): 272-276
Quartu, M.; Polak, J.M.; Del Fiacco, M. 1993: Neuropeptides in the human celiac/superior mesenteric ganglionic complex: An immunohistochemical study. Journal of Chemical Neuroanatomy 6(2): 79-99
Fodor, M.; Pammer, C.; Görcs, T.; Palkovits, M. 1994: Neuropeptides in the human dorsal vagal complex: An immunohistochemical study. Journal of Chemical Neuroanatomy 7(3): 141-157
Ashton, I.K.; Roberts, S.; Jaffray, D.C.; Polak, J.M.; Eisenstein, S.M. 1994: Neuropeptides in the human intervertebral disc. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 12(2): 186-192
Hauser-Kronberger, C.; Hacker, G.W.; Graf, A.H.; Mack, D.; Sundler, F.; Dietze, O.; Frick, J. 1994: Neuropeptides in the human penis: An immunohistochemical study. Journal of Andrology 15(6): 510-520
Cheido, M.; Idova, G. 1997: Neuropeptides in the immunomodulation: Substance P-induced stimulation of immune response in mice. International Journal of Immunopharmacology 19(9-10): 529-533
Speakman, C.T.; Hoyle, C.H.; Kamm, M.A.; Henry, M.M.; Nicholls, R.J.; Burnstock, G. 1993: Neuropeptides in the internal anal sphincter in neurogenic faecal incontinence. International Journal of Colorectal Disease 8(4): 201-205
Nakane, A.; Asano, M.; Miura, T.; Sasaki, S.; Nishikawa, S.; Kohanawa, M.; Minagawa, T. 1998: Neuropeptides in the livers of mice during bacterial infections. Fems Immunology and Medical Microbiology 20(2): 159-164
Lakomy, M.; Häppölä, O.; Majewski, M.; Wasowicz, K. 1993: Neuropeptides in the porcine coeliac-superior mesenteric ganglion. Folia Histochemica et Cytobiologica 31(4): 181-191
Dawidson, I.; Blom, M.; Lundeberg, T.; Theodorsson, E.; Angmar-Månsson, B. 1997: Neuropeptides in the saliva of healthy subjects. Life Sciences 60(4-5): 269-278
Benarroch, E.E. 1994: Neuropeptides in the sympathetic system: presence, plasticity, modulation, and implications. Annals of Neurology 36(1): 6-13
Pudov, V.I.; Grigor'eva, I.F.; Atamanova, N.V.; Boronoev, S.A. 1998: Neuropeptides in the treatment of children with neurosensory hypoacusis. Vestnik Otorinolaringologii 1998(4): 22-24
Hauser Kronberger, C.; Hacker, G.W.; Albegger, K.; Dietze, O. 1994: Neuropeptides in the upper respiratory system. Atemswegs- und Lungenkrankheiten 20(2): 96-111
Sehgal, I.; Thompson, T.C. 1998: Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines. Cancer Research 58(19): 4288-4291
Smith, C.H.; Barker, J.N.; Morris, R.W.; MacDonald, D.M.; Lee, T.H. 1993: Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. Journal of Immunology 151(6): 3274-3282
Bull, H.A.; Hothersall, J.; Chowdhury, N.; Cohen, J.; Dowd, P.M. 1996: Neuropeptides induce release of nitric oxide from human dermal microvascular endothelial cells. Journal of Investigative Dermatology 106(4): 655-660
Shatskaya, N.N.; Komleva, L.M.; Tarasova, L.A. 1992: Neuropeptides inducing the pain syndrome in autonomic and sensory polyneuropathy caused by occupational factors and their role in the mechanisms of laser therapy acupuncture action. Gigiena Truda i Professional'nye Zabolevaniya (1): 25-27
Kaspersen, F.M.; Van Nispen, J.W.; Sperling, E.M.G.; Vader, J.F. 1993: Neuropeptides labelled with sulfur-35. Journal of Labelled Compounds and Radiopharmaceuticals 33(3): 233-243
Nishiyama, H.; Ikeda, H.; Kaneko, T.; Fu, L.; Kudo, M.; Ito, T.; Okubo, T. 1998: Neuropeptides mediate the ozone-induced increase in the permeability of the tracheal mucosa in guinea pigs. American Journal of Physiology 275(2): L231-L238
Okada, T.; Sagara, H.; Fukuda, T. 1997: Neuropeptides modulate human eosinophil and vascular endothelial cell adhesion molecule expression. Dokkyo Journal of Medical Sciences 24(1): 45-57
Numao, T.; Agrawal, D.K. 1992: Neuropeptides modulate human eosinophil chemotaxis. Journal of Immunology 149(10): 3309-3315
Ferguson, T.A.; Fletcher, S.; Herndon, J.; Griffith, T.S. 1995: Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. Journal of Immunology 155(4): 1746-1756
Rabier, M.J.; Farber, E.M.; Wilkinson, D.I. 1993: Neuropeptides modulate leukotriene B4 mitogenicity toward cultured human keratinocytes. Journal of Investigative Dermatology 100(2): 132-136
Santama, N.; Wheeler, C.H.; Burke, J.F.; Benjamin, P.R. 1994: Neuropeptides myomodulin, small cardioactive peptide, and buccalin in the central nervous system of Lymnaea stagnalis: purification, immunoreactivity, and artifacts. Journal of Comparative Neurology 342(3): 335-351
Simonneaux, V. 1995: Neuropeptides of the mammalian pineal gland. Neuroendocrinology Letters 17(2): 115-130
Piggins, H.D.; Antle, M.C.; Rusak, B. 1995: Neuropeptides phase shift the mammalian circadian pacemaker. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 15(8): 5612-5622
Zimmerman, B.J.; Anderson, D.C.; Granger, D.N. 1992: Neuropeptides promote neutrophil adherence to endothelial cell monolayers. American Journal of Physiology 263(5 Pt 1): G678-G682
Tallett, A.; Chilvers, E.R.; Mackinnon, A.C.; Haslett, C.; Sethi, T. 1996: Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines. Peptides 17(4): 665-673
Dietrich, J.B. 1994: Neuropeptides, antagonists and cell proliferation: bombesin as an example. Cellular and Molecular Biology 40(6): 731-746
Levite, M. 1998: Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proceedings of the National Academy of Sciences of the United States of America 95(21): 12544-12549
Pincelli, C.; Fantini, F.; Giannetti, A. 1996: Neuropeptides, nerve growth factor and the skin. Pathologie-Biologie 44(10): 856-859
Boatman, D.; Hall, C.; Goldstein, M.H.; Lesser, R.; Gordon, B. 1997: Neuroperceptual differences in consonant and vowel discrimination: as revealed by direct cortical electrical interference. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior 33(1): 83-98
Skibitskii, V.V.; Petrova, T.R.; Tatarkin, A.N.; Kanorskii, S.G. 1994: Neuropharmaceutical analysis of cardiovascular effects of gidazepam in patients with neurocirculatory dystonia and ventricular arrhythmias. Kardiologiya 34(1-2): 153-155
Lechin, F.; van der Dijs, B.; Orozco, B.; Jara, H.; Rada, I.; Lechin, M.E.; Lechin, A.E. 1998: Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study. Clinical Pharmacology and Therapeutics 64(2): 223-232
Rodgers, R.J. 1995: Neuropharmacological Aspects of Adaptive Pain Inhibition in Murine Victims of Aggression. Aggressive Behavior 21(1): 29-39
Thongpraditchote, S.; Matsumoto, K.; Temsiririrkkul, R.; Tohda, M.; Murakami, Y.; Watanabe, H. 1996: Neuropharmacological actions of Pluchea indica Less root extract in socially isolated mice. Biological and Pharmaceutical Bulletin 19(3): 379-383
Fowler, J.S.; Volkow, N.D.; Wang, G.J.; Pappas, N.; Logan, J.; MacGregor, R.; Alexoff, D.; Wolf, A.P.; Warner, D.; Cilento, R.; Zezulkova, I. 1998: Neuropharmacological actions of cigarette smoke: brain monoamine oxidase B (MAO B) inhibition. Journal of Addictive Diseases 17(1): 23-34
D'yakova, S.D.; Rudenko, L.P. 1993: Neuropharmacological analysis of individual preference of probability and quality of reinforcement. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 43(1): 42-54
Reid, M.S.; Nishino, S.; Tafti, M.; Siegel, J.M.; Dement, W.C.; Mignot, E. 1998: Neuropharmacological characterization of basal forebrain cholinergic stimulated cataplexy in narcoleptic canines. Experimental Neurology 151(1): 89-104
Yamada, K.; Teraoka, T.; Morita, S.; Hasegawa, T.; Nabeshima, T. 1993: Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain. Japanese Journal of Pharmacology 63(4): 423-432
Kanwar, R.S.; Varshneya, C. 1995: Neuropharmacological effects of ivermectin in mice. Indian Journal of Physiology and Pharmacology 39(4): 421-422
Caccia, S.; Confalonieri, S.; Bergami, A.; Fracasso, C.; Anelli, M.; Garattini, S. 1997: Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: A comparison with fluoxetine. Pharmacology Biochemistry and Behavior 57(4): 851-856
Amano, M.; Yamada, K.; Matsuno, K.; Nabeshima, T. 1996: Neuropharmacological effects of sigma receptor ligands: anxiolytic, anti-amnesic and neuroprotective effects. Nihon Shinkei Seishin Yakurigaku Zasshi 16(3): 73-84
Panagis, G.; Spyraki, C. 1996: Neuropharmacological evidence for the role of dopamine in ventral pallidum self-stimulation. Psychopharmacology 123(3): 280-288
Takeda, N.; Hasegawa, S.; Morita, M.; Horii, A.; Uno, A.; Yamatodani, A.; Matsunaga, T. 1995: Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats. Methods and Findings in Experimental and Clinical Pharmacology 17(9): 589-590
Takeda, N.; Hasegawa, S.; Morita, M.; Horii, A.; Uno, A.; Yamatodani, A.; Matsunaga, T. 1995: Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats. Methods and Findings in Experimental and Clinical Pharmacology 17(10): 647-652
Kress, H.G. 1997: Neuropharmacological mechanisms of ketamine. Anaesthesist 46(Suppl 1): S8-S19
Maj, J.; Rogóz, Z.; Skuza, G.; Mazela, H. 1996: Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. European Journal of Pharmacology 315(3): 235-243
David, O.F. 1994: Neuropharmacological properties of Retzius cells in the leech Hirudo medicinalis. Zhurnal Evolyutsionnoi Biokhimii i Fiziologii 30(6): 776-783
Mukhin, E.I.; Nabieva, T.N.; Mukhina, Y.K. 1992: Neuropharmacological recovering of the cat cognitive processes after the destruction of the nucleus basalis of Meynert. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 42(3): 556-565
Ganguli, S.; Hota, D.; Goel, R.K.; Acharya, S.B.; Bhattacharya, S.K. 1996: Neuropharmacological studies on Fusarium toxins--II: Total toxin extract from F. oxysporum. Indian Journal of Experimental Biology 34(5): 418-426
Ganguli, S.; Hota, D.; Goel, R.K.; Acharya, S.B.; Bhattacharya, S.K. 1996: Neuropharmacological studies on Fusarium toxins-III: Neurochemical investigations on total toxin extracts from F. moniliforme and F. oxysporum. Indian Journal of Experimental Biology 34(6): 531-534
Mitra, S.K.; Chakraborti, A.; Bhattacharya, S.K. 1996: Neuropharmacological studies on Panax ginseng. Indian Journal of Experimental Biology 34(1): 41-47
Walker, R.J.; Chen, M.L.; Pedder, S.; Holden-Dye, L.; White, A.R.; Sharma, R. 1993: Neuropharmacological studies on identified central neurones of the snail, Helix aspersa. Zhurnal Vysshei Nervnoi Deiatelnosti Imeni i P Pavlova 43(1): 109-120
Graves, N.M. 1995: Neuropharmacology and Drug Interactions in Clinical Practice. Epilepsia 36(Suppl): S27-S33
Nishino, S.; Reid, M.S.; Dement, W.C.; Mignot, E. 1994: Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 17(8 Suppl): S84-S92
Sastry, B.V. 1995: Neuropharmacology of nicotine: Effects on the autoregulation of acetylcholine release by substance P and methionine enkephalin in rodent cerebral slices and toxicological implications. Clinical and Experimental Pharmacology and Physiology 22(4): 288-290
Pranzatelli, M.R.; Tate, E.; Huang, Y.; Haas, R.H.; Bodensteiner, J.; Ashwal, S.; Franz, D. 1995: Neuropharmacology of progressive myoclonus epilepsy: response to 5-hydroxy-L-tryptophan. Epilepsia 36(8): 783-791
Hakan, R.L.; Eyl, C. 1995: Neuropharmacology of the nucleus accumbens: iontophoretic applications of morphine and nicotine have contrasting effects on single-unit responses evoked by ventral pallidal and fimbria stimulation. Synapse 20(2): 175-184
Hakan, R.L.; Eyl, C.; Henriksen, S.J. 1994: Neuropharmacology of the nucleus accumbens: Systemic morphine effects on single-unit responses evoked by ventral pallidum stimulation. Neuroscience 63(1): 85-93
Phillips, R.-Eugenie; Solis, M.A.ma 1996: Neurophyseta (Lepidoptera: Crambidae) from Costa Rica. Revista de Biologia Tropical 44(2 Part B): 693-717
Mathiasen, J.R.; Larson, E.R.; Ariano, M.A.; Sladek, C.D. 1996: Neurophysin expression is stimulated by dopamine D1 agonist in dispersed hypothalamic cultures. American Journal of Physiology 270(2 Part 2): R404-R412
Wagner, C.K.; Clemens, L.G. 1993: Neurophysin-containing pathway from the paraventricular nucleus of the hypothalamus to a sexually dimorphic motor nucleus in lumbar spinal cord. Journal of Comparative Neurology 336(1): 106-116
Legros, J.J.; Geenen, V. 1996: Neurophysins in central diabetes insipidus. Hormone Research 45(3-5): 182-186
Kraus, N.; McGee, T.; Carrell, T.D.; Sharma, A. 1995: Neurophysiologic bases of speech discrimination. Ear and Hearing 16(1): 19-37
Diaz Atienza, J.; Compam, F.; Blanquez, P.; Sanchez, F. 1998: Neurophysiologic abnormalities in developmental dysphasias and response to CDP-choline. Advances in Therapy 15(1): 8-13
Vladimirov, M.; Thalhammer, J.G.; Hunt, N.; Feldman, H.S.; Strichartz, G. 1997: Neurophysiologic actions and neurological consequences of veratridine on the rat sciatic nerve. Anesthesiology 86(4): 945-956
Kaplan, P.W.; Tusa, R.J. 1993: Neurophysiologic and clinical correlations of epileptic nystagmus. Neurology 43(12): 2508-2514
Tawa, R.; Matsuda, H.; Morimoto, T.; Nagao, H.; Matsuda, H.; Ohnishi, A. 1992: Neurophysiologic and histopathologic studies in a case of congenital sensory neuropathy with anhidrosis. No To Hattatsu 24(6): 542-547
Wehling, P.; Cleveland, S.J.; Heininger, K.; Schulitz, K.P.; Reinecke, J.; Evans, C.H. 1996: Neurophysiologic changes in lumbar nerve root inflammation in the rat after treatment with cytokine inhibitors. Evidence for a role of interleukin-1. Spine 21(8): 931-935
Stigsby, B.; Yarworth, S.M.; Rahbeeni, Z.; Dabbagh, O.; de Gier Munk, C.; Abdo, N.; Brismar, J.; Gascon, G.G.; Ozand, P.T. 1994: Neurophysiologic correlates of organic acidemias: a survey of 107 patients. Brain and Development 16(Suppl): 125-144
Mikhaĭlova, E.S.; Tsutsul'kovskaia, M.Ia.; Oleĭchik, I.V. 1998: Neurophysiologic correlations of cognitive dysfunction in depressed patients with syndrome of juvenile asthenic deficiency. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 98(2): 20-25
Noël, P.; Deltenre, P.; Lamoureux, J.; Capouet, V.; de Villé, A.; Govaerts, M.J. 1994: Neurophysiologic detection of a unilateral motor deficit occurring during the noncritical phase of scoliosis surgery. Spine 19(21): 2399-2402
Ogino, T.; Hata, H.; Minakuchi, E.; Iyoda, K.; Narahara, K.; Ohtahara, S. 1994: Neurophysiologic dysfunction in hypomelanosis of Ito: EEG and evoked potential studies. Brain and Development 16(5): 407-412
Edwards, L.L.; Wszolek, Z.K.; Normand, M.M. 1995: Neurophysiologic evaluation of cyclosporine toxicity associated with bone marrow transplantation. Acta Neurologica Scandinavica 92(5): 423-429
Gorman, P.H.; Kikta, D.G.; Peckham, P.H. 1998: Neurophysiologic evaluation of lower motor neuron damage in tetraplegia. Muscle and Nerve 21(10): 1321-1323
Mal'mberg, S.A.; Zavadenko, N.N.; Petrukhin, A.A.; Evgrafov, O.V.; Maslova, O.I. 1997: Neurophysiologic examination in family with spinal and bulbar Kennedy's amyotrophy: Diagnosis of preclinical stage of disease in children. Pediatriya (Moscow) 1997(2): 38-42
Weber, G.; Siragusa, V.; Rondanini, G.F.; Prina Cerai, L.M.; Mora, S.; Colombini, J.; Medaglini, S.; Lia, C.; Locatelli, T.; Comi, G. 1995: Neurophysiologic studies and cognitive function in congenital hypothyroid children. Pediatric Research 37(6): 736-740
Tayama, M.; Hashimoto, T.; Mori, K.; Miyazaki, M.; Yoshimoto, T.; Kuroda, Y. 1994: Neurophysiologic studies on patients with migration disorder. No to Hattatsu 26(4): 308-312
Nuwer, J.M.; Nuwer, M.R. 1997: Neurophysiologic surgical monitoring staffing patterns in the USA. Electroencephalography and Clinical Neurophysiology 103(6): 616-620,.
Restuccia, D.; Di Lazzaro, V.; Valeriani, M.; Oliviero, A.; Le Pera, D.; Colosimo, C.; Burdi, N.; Cappa, M.; Bertini, E.; Di Biase, A.; Tonali, P. 1997: Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement. Brain: a Journal of Neurology 120: 1139-1148
Meizerov, E.E.; Blinov, A.V.; Reshetniak, V.K. 1996: Neurophysiological analysis of analgesic effect of phentanyl and moradol. Anesteziologiia i Reanimatologiia 1996(4): 10-13
Rusak, B.; Abe, H.; Mason, R.; Piggins, H.D.; Ying, S.W. 1993: Neurophysiological analysis of circadian rhythm entrainment. Journal of Biological Rhythms 8(Suppl): S39-S45
Voronin, L.; Byzov, A.; Kleschevnikov, A.; Kozhemyakin, M.; Kuhnt, U.; Volgushev, M. 1995: Neurophysiological analysis of long-term potentiation in mammalian brain. Behavioural Brain Research 66(1-2): 45-52
Grue, C., E.; Gibert, P., L.; Seeley, M., E. 1997: Neurophysiological and behavioral changes in non-target wildlife exposed to organophosphate and carbamate pesticides: Thermoregulation, food consumption, and reproduction. American Zoologist 37(4): 369-388
Comi, G.; Martinelli, V.; Locatelli, T.; Leocani, L.; Medaglini, S. 1998: Neurophysiological and cognitive markers of disease evolution in multiple sclerosis. Multiple Sclerosis 4(3): 260-265
Setzer, J.V.; Brightwell, W.S.; Russo, J.M.; Johnson, B.L.; Lynch, D.W.; Madden, G.; Burg, J.R.; Sprinz, H. 1996: Neurophysiological and neuropathological evaluation of primates exposed to ethylene oxide and propylene oxide. Toxicology and Industrial Health 12(5): 667-682
Cullum, C.M.; Harris, J.G.; Waldo, M.C.; Smernoff, E.; Madison, A.; Nagamoto, H.T.; Griffith, J.; Adler, L.E.; Freedman, R. 1993: Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophrenia Research 10(2): 131-141
Trubnikov, V.; Uvarova, L.; Alfimova, M.; Orlova, V.; Ozerova, N.; Abrosimov, N. 1993: Neurophysiological and psychological predictors of genetic risk for schizophrenia. Behavior Genetics 23(5): 455-459
Fierro, B.; Daniele, O.; Aloisio, A.; Buffa, D.; La Bua, V.; Oliveri, M.; Manfre, L.; Brighina, F. 1998: Neurophysiological and radiological findings in myotonic dystrophy patients. European Journal of Neurology 5(1): 89-94,.
Lozza, A.; Proietti Cecchini, A.; Afra, J.; Schoenen, J. 1998: Neurophysiological approach to primary headache pathophysiology. Cephalalgia: An International Journal of Headache 18(Suppl): 12-16
Jastreboff, P.J.; Gray, W.C.; Gold, S.L. 1996: Neurophysiological approach to tinnitus patients. American Journal of Otology 17(2): 236-240
Wiegand, H.; Altmann, L. 1994: Neurophysiological aspects of hippocampal neurotoxicity. Neurotoxicology 15(3): 451-458
Wiebalck, A.; Zenz, M. 1997: Neurophysiological aspects of pain. Anaesthesist 46(Suppl 3): S147-S153
Stumpner, A.; Ronacher, B. 1994: Neurophysiological aspects of song pattern recognition and sound localization in grasshoppers. American Zoologist 34(6): 696-705
Murrison, A.W.; Glasspool, E.; Pethybridge, R.J.; Francis, T.J.; Sedgwick, E.M. 1994: Neurophysiological assessment of divers with medical histories of neurological decompression illness. Occupational and Environmental Medicine 51(11): 730-734
Connolly, S.; Manji, H.; McAllister, R.H.; Griffin, G.B.; Loveday, C.; Kirkis, C.; Sweeney, B.; Sartawi, O.; Durrance, P.; Fell, M. 1995: Neurophysiological assessment of peripheral nerve and spinal cord function in asymptomatic HIV-1 infection: Results from the UCMSM/Medical Research Council neurology cohort. Journal of Neurology 242(6): 406-414
Denislic, M.; Meh, D. 1994: Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome. Clinical Investigator 72(11): 822-829
Commissiong, J.W.; Sauve, Y. 1993: Neurophysiological basis of functional recovery in the neonatal spinalized rat. Experimental Brain Research 96(3): 473-479
Ngassapa, D. 1996: Neurophysiological basis, aetiology and clinical aspects of hypersensitive teeth. East African Medical Journal 73(12): 775-778
Nikitin, V.P.; Kozyrev, S.A.; Samoilov, M.O. 1992: Neurophysiological changes and bound calcium dynamics in training associative learning of snail Helix lucorum. Neirofiziologiya 24(6): 691-701
Xu, Z.C. 1995: Neurophysiological changes of spiny neurons in rat neostriatum after transient forebrain ischemia: An in vivo intracellular recording and staining study. Neuroscience 67(4): 823-836
Padua, L.; Lomonaco, M.; Gregori, B.; Valente, E.M.; Padua, R.; Tonali, P. 1997: Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurologica Scandinavica 96(4): 211-217
Padua, L.; Lo Monaco, M.; Padua, R.; Gregori, B.; Tonali, P. 1997: Neurophysiological classification of carpal tunnel syndrome: Assessment of 600 symptomatic hands. Italian Journal of Neurological Sciences 18(3): 145-150
Hahn, S.M.; Lepinski, D.L.; DeLuca, A.M.; Mitchell, J.B.; Pellmar, T.C. 1995: Neurophysiological consequences of nitroxide antioxidants. Canadian Journal of Physiology and Pharmacology 73(3): 399-403
Kastner, S.; Crook, J.M..; Pei, X.; Creutzfeldt, O.D.. 1992: Neurophysiological correlates of colour induction on white surfaces. European Journal of Neuroscience 4(11): 1079-1086
Dudkin, K.N.; Kruchinin, V.K.; Chueva, I.V. 1995: Neurophysiological correlates of improvement of the cognitive characteristics in modification of NMDA-ergic structures of the prefrontal cortex in monkeys. Fiziologicheskii Zhurnal Imeni I M Sechenova 81(1): 32-39
Pauli, P.; Lutzenberger, W.; Birbaumer, N.; Rickard, T.C.; Bourne, L.E. 1996: Neurophysiological correlates of mental arithmetic. Psychophysiology 33(5): 522-529
Fallgatter, A.J.; Mueller, T.J.; Strik, W.K. 1997: Neurophysiological correlates of mental imagery in different sensory modalities. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 25(2): 145-153
Skrandies, W.; Fahle, M. 1994: Neurophysiological correlates of perceptual learning in the human brain. Brain Topography 7(2): 163-168
Kemenes, G.; Zakharov, I.S.; Vehovszky, A.; Rózsa, K.S. 1993: Neurophysiological correlates of tactile stimulus-induced whole-body eversion, a novel type of behavior in the snail Helix pomatia L. Brain Research 612(1-2): 16-27
Sawyer, S.J.; Dowse, H.B.; Shick, J.M.lcolm 1994: Neurophysiological correlates of the behavioral response to light in the sea anemone Anthopleura elegantissima. Biological Bulletin (woods Hole). 186(2): 201
Chibisova, A.N.; Shandurina, A.N. 1993: Neurophysiological correlates of the central motor disorder rehabilitation by the liquor transfusion method. Fiziologiya Cheloveka 19(4): 39-45
Staras, K.; Kemenes, G.; Benjamin, P.R. 1998: Neurophysiological correlates of unconditioned and conditioned feeding behavior in the pond snail Lymnaea stagnalis. Journal of Neurophysiology 79(6): 3030-3040
Shever'ova, V.M. 1997: Neurophysiological effects of beta-blocker obsidan under conditions of modelling of the emotional stress. Fiziolohichnyi Zhurnal 43(1-2): 31-39
Sandström, M.; Lyskov, E.; Berglund, A.; Medvedev, S.; Mild, K.H. 1997: Neurophysiological effects of flickering light in patients with perceived electrical hypersensitivity. Journal of Occupational and Environmental Medicine 39(1): 15-22
Giry, P. 1992: Neurophysiological effects of hyperbaric atmospheres: Some reflections. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1992(13): 159-160
Rose, J.D.; Kinnaird, J.R.; Moore, F.L. 1995: Neurophysiological effects of vasotocin and corticosterone on medullary neurons: implications for hormonal control of amphibian courtship behavior. Neuroendocrinology 62(4): 406-417
Voinov, V.B.; Belova, E.I.; Kiroi, V.N.; Ryabukhin, Y.I. 1995: Neurophysiological estimation of the trimethadione effect on the cat brain functional state. Fiziologicheskii Zhurnal Imeni I M Sechenova 81(3): 1-7
Del Carro, U.; Riva, D.; Comi, G.C.; Locatelli, T.; Magnani, G.; Levati, N.; Viganó, R.; Sambruni, I.; Canal, N. 1993: Neurophysiological evaluation in detrusor instability. Neurourology and Urodynamics 12(5): 455-462
Somnier, F.E.; Trojaborg, W. 1993: Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population. Electroencephalography and Clinical Neurophysiology 89(2): 73-87
Qiu, W.W.; Yin, S.S.; Stucker, F.J.; Hoasjoe, D.K. 1997: Neurophysiological evaluation of acute facial paralysis in children. International Journal of Pediatric Otorhinolaryngology 39(3): 223-236
Paradiso, G.; Casas Parera, I. 1993: Neurophysiological evaluation of diabetic polyneuropathy in patients treated with buflomedil and placebo. Prensa Medica Argentina 80(1): 46-51
Alves, M.; Conceição, I.; Luis, M.L. 1997: Neurophysiological evaluation of sexual dysfunction in familial amyloidotic polyneuropathy--Portuguese type. Acta Neurologica Scandinavica 96(3): 163-166
Baldeweg, T.; Riccio, M.; Gruzelier, J.; Hawkins, D.; Burgess, A.; Irving, G.; Stygall, J.; Catt, S.; Catalan, J. 1995: Neurophysiological evaluation of zidovudine in asymptomatic HIV-1 infection: A longitudinal placebo-controlled study. Journal of the Neurological Sciences 132(2): 162-169
Steinmetz, M.A.; Constantinidis, C. 1995: Neurophysiological evidence for a role of posterior parietal cortex in redirecting visual attention. Cerebral Cortex 5(5): 448-456
Polat, U.; Norcia, A.M. 1996: Neurophysiological evidence for contrast dependent long-range facilitation and suppression in the human visual cortex. Vision Research 36(14): 2099-2109
Stiller, R.U.; Grubb, B.D.; Schaible, H.G. 1993: Neurophysiological evidence for increased kappa opioidergic control of spinal cord neurons in rats with unilateral inflammation at the ankle. European Journal of Neuroscience 5(11): 1520-1527
Schendan, H.E.; Ganis, G.; Kutas, M. 1998: Neurophysiological evidence for visual perceptual categorization of words and faces within 150 ms. Psychophysiology 35(3): 240-251
Tinazzi, M.; Zanette, G.; Volpato, D.; Testoni, R.; Bonato, C.; Manganotti, P.; Miniussi, C.; Fiaschi, A. 1998: Neurophysiological evidence of neuroplasticity at multiple levels of the somatosensory system in patients with carpal tunnel syndrome. Brain: a Journal of Neurology 121: 1785-1794
Ueberall, M.A.; Skirl, G.; Strassburg, H.M.; Wenzel, D.; Hertzberg, H.; Langer, T.; Meier, W.; Berger-Jones, K.; Huk, W.J.; Korinthenberg, R.; Beck, J.D. 1997: Neurophysiological findings in long-term survivors of acute lymphoblastic leukaemia in childhood treated with the BFM protocol 81 SR-A/B. European Journal of Pediatrics 156(9): 727-733
Sainio, K. 1997: Neurophysiological findings in neuronal ceroid lipofuscinoses. Neuropediatrics 28(1): 70
Lang, A.H.; Hirvasniemi, A.; Siivola, J. 1997: Neurophysiological findings in the northern epilepsy syndrome. Acta Neurologica Scandinavica 95(1): 1-8
Yagyu, T. 1994: Neurophysiological findings on the effects of fragrance: Lavender and Jasmine. Integrative Psychiatry 10(2): 62-67
Richard, P.; Renault, F.; Ostré, C.; Auzoux-Chevé, M. 1994: Neurophysiological follow-up in two children with Creutzfeldt-Jakob disease after human growth hormone treatment. Electroencephalography and Clinical Neurophysiology 91(2): 100-107
Engel, L.S.; Keifer, M.C.; Checkoway, H.; Robinson, L.R.; Vaughan, T.L. 1998: Neurophysiological function in farm workers exposed to organophosphate pesticides. Archives of Environmental Health 53(1): 7-14
Sudakov, K.V. 1993: Neurophysiological grounds of dominating motivation. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1993(7): 42-48
Hutchison, W.D.; Allan, R.J.; Opitz, H.; Levy, R.; Dostrovsky, J.O.; Lang, A.E.; Lozano, A.M. 1998: Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Annals of Neurology 44(4): 622-628
Lingenfelser, T.; Buettner, U.W.; Sommerwerck, U.; Renn, W.; Eggstein, M.; Jakober, B. 1993: Neurophysiological impairments in IDDM patients during euglycemia and hypoglycemia. Diabetes Care 16(11): 1438-1445
Nicol, A.U.; Brown, M.W.; Horn, G. 1995: Neurophysiological investigations of a recognition memory system for imprinting in the domestic chick. European Journal of Neuroscience 7(4): 766-776
Murtazina, E.P. 1995: Neurophysiological mechanisms of neurotropin action on avoidance conditioning and extinction in rabbits. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 45(4): 748-756
Capaday, C. 1997: Neurophysiological methods for studies of the motor system in freely moving human subjects. Journal of Neuroscience Methods 74(2): 201-218
Araki, S.; Yokoyama, K.; Murata, K. 1997: Neurophysiological methods in occupational and environmental health: methodology and recent findings. Environmental Research 73(1-2): 42-51
Uclés, P.; Lorente, S.; Rosa, F. 1996: Neurophysiological methods testing the psychoneural basis of attention deficit hyperactivity disorder. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 12(4): 215-217
Jastreboff, P.J.; Hazell, J.W.; Graham, R.L. 1994: Neurophysiological model of tinnitus: dependence of the minimal masking level on treatment outcome. Hearing Research 80(2): 216-232
Le Feber, J.; Van Asselt, E.; Van Mastrigt, R. 1997: Neurophysiological modeling of voiding in rats: bladder pressure and postganglionic bladder nerve activity. American Journal of Physiology 272(1 Pt 2): R413-R421
Feber, J.L.; van Asselt, E.; van Mastrigt, R. 1998: Neurophysiological modeling of voiding in rats: urethral nerve response to urethral pressure and flow. American Journal of Physiology 274(5): R1473-R1481
Singh, G.; Avasthi, G.; Khurana, D.; Whig, J.; Mahajan, R. 1998: Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalography and Clinical Neurophysiology 107(2): 140-148
Montalbetti, L.; Bo, P.; Romani, A.; Ciuffreda, A.; Savoldi, F. 1993: Neurophysiological parameters during halothane anaesthesia in experimental models of cerebral ischemia. Bollettino della Societa Italiana di Biologia Sperimentale 69(3): 179-186
Lebedev, A.N. 1993: Neurophysiological parameters of human memory. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 43(2): 277-285
Sterio, D.; Berić, A.; Dogali, M.; Fazzini, E.; Alfaro, G.; Devinsky, O. 1994: Neurophysiological properties of pallidal neurons in Parkinson's disease. Annals of Neurology 35(5): 586-591
Herning, R.I.; Guo, X.; Better, W.E.; Weinhold, L.L.; Lange, W.R.; Cadet, J.L.; Gorelick, D.A. 1997: Neurophysiological signs of cocaine dependence: increased electroencephalogram beta during withdrawal. Biological Psychiatry 41(11): 1087-1094
Antonaci, F.; Sandrini, G.; Danilov, A.; Sand, T. 1994: Neurophysiological studies in chronic paroxysmal hemicrania and hemicrania continua. Headache 34(8): 479-483
Coşkun, T.; Topçu, M.; Ustündağ, I.; Ozalp, I.; Renda, Y.; Ciğer, A.; Nurlu, G. 1993: Neurophysiological studies of patients with classical phenylketonuria: evaluation of results of IQ scores, EEG and evoked potentials. Turkish Journal of Pediatrics 35(1): 1-10
Nezu, A. 1995: Neurophysiological study in Pelizaeus-Merzbacher disease. Brain and Development 17(3): 175-181
Cepeda, C.; Walsh, J.P.; Peacock, W.; Buchwald, N.A.; Levine, M.S. 1994: Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro. Neuroscience 59(1): 89-103
Sloan, E.P.; Fenton, G.W.; Kennedy, N.S.; MacLennan, J.M. 1994: Neurophysiology and SPECT cerebral blood flow patterns in dementia. Electroencephalography and Clinical Neurophysiology 91(3): 163-170
Manteca, X. 1998: Neurophysiology and assessment of welfare. Meat Science 49s1: S205-S218
Rolls, E.T. 1994: Neurophysiology and cognitive functions of the striatum. Revue Neurologique (Paris) 150(8-9): 648-660
Finch, D.M.; Gigg, J.; Tan, A.M.; Kosoyan, O.P. 1995: Neurophysiology and neuropharmacology of projections from entorhinal cortex to striatum in the rat. Brain Research 670(2): 233-247
Levick, W.R.; Thibos, L.N. 1993: Neurophysiology of central retinal degeneration in cat. Visual Neuroscience 10(3): 499-509
Mel'nikova, T.S.; Nikiforov, A.I. 1992: Neurophysiology of deep brain regions in retarded depression: Its features and effects of course treatment. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1992(8): 21-25
Dietz, V. 1997: Neurophysiology of gait disorders: Present and future applications. Electroencephalography and Clinical Neurophysiology 103(3): 333-355
Dudek, F.E.; Wuarin, J.P.; Tasker, J.G.; Kim, Y.I.; Peacock, W.J. 1995: Neurophysiology of neocortical slices resected from children undergoing surgical treatment for epilepsy. Journal of Neuroscience Methods 59(1): 49-58
Gatt, M.T. 1995: Neurophysiology of perineal pain. Contraception Fertilite Sexualite 23(6): 404-406
Debru, C. 1994: Neurophysiology of sleep and dream in the last four decades, considered from a philosophical point of view. Biologisches Zentralblatt 113(2): 151-156
Widdicombe, J.G. 1995: Neurophysiology of the cough reflex. European Respiratory Journal 8(7): 1193-1202
Ito, M. 1993: Neurophysiology of the nodulofloccular system. Revue Neurologique (Paris) 149(11): 692-697
Bekkers, J.M. 1998: Neurophysiology: Are autapses prodigal synapses?. Current Biology: Cb 8(2): R52-R55
Wickersham, I.; Groh, J.M. 1998: Neurophysiology: Electrically evoking sensory experience. Current Biology: Cb 8(12): R412-R414
Horwitz, G.D.; Newsome, W.T. 1998: Neurophysiology: Sensing and categorizing. Current Biology: Cb 8(11): R376-R378
He, Z.; Tessier-Lavigne, M. 1997: Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90(4): 739-751
Kolodkin, A.L.; Levengood, D.V.; Rowe, E.G.; Tai, Y.T.; Giger, R.J.; Ginty, D.D. 1997: Neuropilin is a semaphorin III receptor. Cell 90(4): 753-762
Migdal, M.; Huppertz, B.; Tessler, S.; Comforti, A.; Shibuya, M.; Reich, R.; Baumann, H.; Neufeld, G. 1998: Neuropilin-1 is a placenta growth factor-2 receptor. Journal of Biological Chemistry 273(35): 22272-22278
Chen, H.; Chédotal, A.; He, Z.; Goodman, C.S.; Tessier-Lavigne, M. 1997: Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19(3): 547-559
Párducz, A.; Szilágyi, T.; Hoyk, S.; Naftolin, F.; Garcia-Segura, L.M. 1996: Neuroplastic changes in the hypothalamic arcuate nucleus: The estradiol effect is accompanied by increased exoendocytotic activity of neuronal membranes. Cellular and Molecular Neurobiology 16(2): 259-269
Gynther, B.D.; Calford, M.B.; Sah, P. 1998: Neuroplasticity and psychiatry. Australian and New Zealand Journal of Psychiatry 32(1): 119-128
Payne, B.R.; Lomber, S.G. 1998: Neuroplasticity in the cat's visual system. Origin, termination, expansion, and increased coupling of the retino-geniculo-middle suprasylvian visual pathway following early ablations of areas 17 and 18. Experimental Brain Research 121(3): 334-349
Luck, M.S.; Dahl, J.L.; Boyeson, M.G.; Bass, P. 1993: Neuroplasticity in the smooth muscle of the myenterically and extrinsically denervated rat jejunum. Cell and Tissue Research 271(2): 363-374
Schwaber, M.K.; Garraghty, P.E.; Kaas, J.H. 1993: Neuroplasticity of the adult primate auditory cortex following cochlear hearing loss. American Journal of Otology 14(3): 252-258
Jobe, T.H.; Fichtner, C.G.; Port, J.D.; Gaviria, M.M. 1995: Neuropoiesis: Proposal for a connectionistic neurobiology. Medical Hypotheses 45(2): 147-163
Fann, M.J.; Patterson, P.H. 1994: Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proceedings of the National Academy of Sciences of the United States of America 91(1): 43-47
Leonard, N.; Hourihane, D.O.; Whelan, A. 1995: Neuroproliferation in the mucosa is a feature of coeliac disease and Crohn's disease. Gut 37(6): 763-765
Cavaletti, G.; Cascinu, S.; Venturino, P.; Tedeschi, M.; Tredici, G. 1996: Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Research 16(5b): 3149-3159
Romano, C.; Price, M.; Bai, H.Y.; Olney, J.W. 1993: Neuroprotectants in Honghua: glucose attenuates retinal ischemic damage. IOVS Investigative Ophthalmology and Visual Science 34(1): 72-80
Urenjak, J.; Obrenovitch, T.P. 1998: Neuroprotection - rationale for pharmacological modulation of Na+-channels. Amino Acids (vienna). 14(1-3): 151-158
Lock, E.A.; Gyte, A.; Duffell, S.J.; Simpson, M.G.; Wyatt, I. 1997: Neuroprotection afforded by MK-801 against L-2-chloropropionic acid-induced cerebellar granule cell necrosis in the rat. Toxicology 123(1-2): 41-51
Lekieffre, D.; Benavides, J.; Scatton, B.; Nowicki, J.P.erre 1997: Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model. Brain Research 776(1-2): 88-95,. 21
Bômont, L.; MacKenzie, E.T. 1995: Neuroprotection after focal cerebral ischaemia in hyperglycaemic and diabetic rats. Neuroscience Letters 197(1): 53-56
Nurse, S.; Corbett, D. 1996: Neuroprotection after several days of mild, drug-induced hypothermia. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 16(3): 474-480
Panizzon, K.L.; Dwyer, B.E.; Nishimura, R.N.; Wallis, R.A. 1996: Neuroprotection against CA1 injury with metalloporphyrins. Neuroreport 7(2): 662-666
Oosterink, B.J.; Korte, S.M.; Nyakas, C.; Korf, J.; Luiten, P.G. 1998: Neuroprotection against N-methyl-D-aspartate-induced excitotoxicity in rat magnocellular nucleus basalis by the 5-HT1A receptor agonist 8-OH-DPAT. European Journal of Pharmacology 358(2): 147-152
Luiten, P.G.; Douma, B.R.; Van der Zee, E.A.; Nyakas, C. 1995: Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration: a Journal for Neurodegenerative Disorders Neuroprotection and Neuroregeneration 4(3): 307-314
Wallis, R.A.; Panizzon, K.L.; Henry, D.; Wasterlain, C.G. 1993: Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation. Neuroreport 5(3): 245-248
Behl, C.; Skutella, T.; Lezoualc'h, F.; Post, A.; Widmann, M.; Newton, C.J.; Holsboer, F. 1997: Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molecular Pharmacology 51(4): 535-541
Beit-Yannai, E.; Trembovler, V.; Horowitz, M.; Lazarovici, P.; Kohen, R.; Shohami, E. 1998: Neuroprotection against oxidative stress by serum from heat acclimated rats. Neuroscience Letters 254(2): 89-92
Wenk, G.L. 1995: Neuroprotection and selective vulnerability of neurons within the nucleus basalis magnocellularis. Behavioural Brain Research 72(1-2): 17-24
Hoffman, C.A.; Boast, C.A. 1995: Neuroprotection by MK-801 in temperature maintained gerbils. Brain Research Bulletin 38(4): 405-409
Steinberg, G.K.; Yoon, E.J.; Kunis, D.M.; Sun, G.H.; Maier, C.M.; Grant, G.A. 1995: Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing. Neuroscience 64(1): 99-107
Rauhala, P.; Lin, A.M.; Chiueh, C.C. 1998: Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 12(2): 165-173
Grilli, M.; Pizzi, M.; Memo, M.; Spano, P. 1996: Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274(5291): 1383-1385
Pringle, A.K.; Iannotti, F.; Wilde, G.J.; Chad, J.E.; Seeley, P.J.; Sundstrom, L.E. 1997: Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Research 755(1): 36-46
Muralikrishnan, D.; Mohanakumar, K.P. 1998: Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB Journal 12(10): 905-912
Fox, M.W.; Anderson, R.E.; Meyer, F.B. 1993: Neuroprotection by corticotropin releasing factor during hypoxia in rat brain. Stroke 24(7): 1072-5; Discussion 1075-6
Yang, Y.; Shuaib, A.; Li, Q.; Siddiqui, M.M. 1998: Neuroprotection by delayed administration of topiramate in a rat model of middle cerebral artery embolization. Brain Research 804(2): 169-176
Sereghy, T.; Overgaard, K.; Boysen, G. 1993: Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats. Stroke 24(11): 1702-1708
Hori, K.; Katayama, M.; Sato, N.; Ishii, K.; Waga, S.; Yodoi, J. 1994: Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX). Brain Research 652(2): 304-310
Giusti, P.; Lipartiti, M.; Franceschini, D.; Schiavo, N.; Floreani, M.; Manev, H. 1996: Neuroprotection by melatonin from kainate-induced excitotoxicity in rats. FASEB Journal 10(8): 891-896
Krieglstein, J.; Seif, E.N.sr, M.; Lippert, K. 1997: Neuroprotection by memantine as increased by hypothermia and nimodipine. European Journal of Pharmaceutical Sciences 5(2): 71-77
Mohanakumar, K.P.; Hanbauer, I.; Chiueh, C.C. 1998: Neuroprotection by nitric oxide against hydroxyl radical-induced nigral neurotoxicity. Journal of Chemical Neuroanatomy 14(3-4): 195-205
Wenk, G.L.; Baker, L.M.; Stoehr, J.D.; Hauss-Wegrzyniak, B.; Danysz, W. 1998: Neuroprotection by novel antagonists at the NMDA receptor channel and glycineB sites. European Journal of Pharmacology 347(2-3): 183-187
Stern, G. 1998: Neuroprotection by selegiline and other MAO inhibitors. Journal of Neural Transmission. Supplementum 52: 99-107
Maier, C.M.; Sun, G.H.; Kunis, D.M.; Giffard, R.G.; Steinberg, G.K. 1995: Neuroprotection by the N-methyl-D-aspartate receptor antagonist CGP 40116: In vivo and in vitro studies. Journal of Neurochemistry 65(2): 652-659
Maier, C.; Steinberg, G.K.; Sun, G.H.; Zhi, G.T.; Maze, M. 1993: Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology 79(2): 306-312
Packer, L.; Tritschler, H.J.; Wessel, K. 1997: Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radical Biology and Medicine 22(1-2): 359-378
Zapater, P.; Moreno, J.; Horga, J.F. 1997: Neuroprotection by the novel calcium antagonist PCA50938, nimodipine and flunarizine, in gerbil global brain ischemia. Brain Research 772(1-2): 57-62
Stolc, S.; Vlkolinský, R.; Pavlásek, J. 1997: Neuroprotection by the pyridoindole stobadine: A minireview. Brain Research Bulletin 42(5): 335-340
Steinberg, G.K.; Kunis, D.; DeLaPaz, R.; Poljak, A. 1993: Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurological Research 15(3): 174-180
Koller, W.C. 1998: Neuroprotection for Parkinson's disease. Annals of Neurology 44(3 Suppl 1): S155-S159
Gidday, J.M.; Fitzgibbons, J.C.; Shah, A.R.; Park, T.S. 1994: Neuroprotection from ischemic brain injury by hypoxic preconditioning in the neonatal rat. Neuroscience Letters 168(1-2): 221-224
Baubichon, D.; Mestries, J.C.; Brochier, G.; Lallement, G. 1997: Neuroprotection given by GK-11 when used in addition to the emergency treatment of organophosphate intoxication. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1997(18): 137-138
Tymianski, M. 1995: Neuroprotection in vitro and in vivo by cell membrane-permeant Ca2+ chelators. Clinical and Experimental Pharmacology and Physiology 22(4): 299-300
Wenk, G.L.; Zajaczkowski, W.; Danysz, W. 1997: Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B. Behavioural Brain Research 83(1-2): 129-133
Maiese, K.; Tenbroeke, M.; Kue, I. 1997: Neuroprotection of lubeluzole is mediated through the signal transduction pathways of nitric oxide. Journal of Neurochemistry 68(2): 710-714
Greiner, C.; Hülsmann, S.; Wassmann, H.; Moskopp, D.; Schmidinger, A.; Wölfer, J.; Köhling, R.; Lücke, A.; Speckmann, E. 1998: Neuroprotection of mild hypothermia: Differential effects. Brain Research 786(1-2): 267-269
Baumgartner, B.J.; Shine, H.D. 1998: Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Experimental Neurology 153(1): 102-112
Overgaard, K.; Sereghy, T.; Pedersen, H.; Boysen, G. 1993: Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke. Neurological Research 15(5): 344-349
Lo, E.H.; Pierce, A.R.; Mandeville, J.B.; Rosen, B.R. 1997: Neuroprotection with NBQX in rat focal cerebral ischemia. Effects on ADC probability distribution functions and diffusion-perfusion relationships. Stroke 28(2): 439-46; Discussion 446-7
Hong, S.C.; Goto, Y.; Lanzino, G.; Soleau, S.; Kassell, N.F.; Lee, K.S. 1994: Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25(3): 663-669
Shuaib, A.; Waqaar, T.; Ijaz, M.S.; Kanthan, R.; Wishart, T.; Howlett, W. 1996: Neuroprotection with felbamate: A 7- and 28-day study in transient forebrain ischemia in gerbils. Brain Research 727(1-2): 65-70
Gorio, A.; Vergani, L.; Lesma, E.; Di Giulio, A.M. 1998: Neuroprotection, neuroregeneration, and interaction with insulin-like growth factor-I: Novel non-anticoagulant action of glycosaminoglycans. Journal of Neuroscience Research 51(5): 559-562
Kempski, O.S. 1994: Neuroprotection. Models and basic principles. Der Anaesthesist 43(Suppl): S25-S33
Pierard, C.; Lallement, G.; Masqueliez, C.; Baubichon, D.; Pernot-Marino, I.; Peres, M.; Lagarde, D. 1997: Neuroprotection: New property of modafinil. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1997(18): 155-156
Dawson, T.M.; Hung, K.; Dawson, V.L.; Steiner, J.P.; Snyder, S.H. 1995: Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase. Annals of Neurology 37(1): 115-118
Lysko, P.G.; Webb, C.L.; Yue, T.L.; Gu, J.L.; Feuerstein, G. 1994: Neuroprotective effects of tetrodotoxin as a Na+ channel modulator and glutamate release inhibitor in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 25(12): 2476-2482
Wiard, R.P.; Dickerson, M.C.; Beek, O.; Norton, R.; Cooper, B.R. 1995: Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke 26(3): 466-472
Furukawa, K.; Estus, S.; Fu, W.; Mark, R.J.; Mattson, M.P. 1997: Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. Journal of Cell Biology 136(5): 1137-1149
Fossom, L.H.; Von Lubitz, D.K.; Lin, R.C.; Skolnick, P. 1995: Neuroprotective actions of 1-aminocyclopropanecarboxylic acid (ACPC): a partial agonist at strychnine-insensitive glycine sites. Neurological Research 17(4): 265-269
Palmer, G.C.; Cregan, E.C.; Borrelli, A.R.; Harris, E.W.; Stagnitto, M.L.; Colombo, P.; Kaiser, F.C.; Murray, R.J.; Griffith, R.C.; Strand, J.C. 1995: Neuroprotective actions of 2-amino-N-(1,2-diphenylethyl)-acetamide hydrochloride (FPL 13950) in animal models of hypoxia and global ischemia. Journal of Pharmacology and Experimental Therapeutics 274(2): 991-1000
Butcher, S.P.; Henshall, D.C.; Teramura, Y.; Iwasaki, K.; Sharkey, J. 1997: Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 17(18): 6939-6946
Farinelli, S.E.; Greene, L.A.; Friedman, W.J. 1998: Neuroprotective actions of dipyridamole on cultured CNS neurons. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(14): 5112-5123
Hall, E.D. 1993: Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cellular and Molecular Neurobiology 13(4): 415-432
Bar-Joseph, A.; Berkovitch, Y.; Adamchik, J.; Biegon, A. 1994: Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils. Molecular and Chemical Neuropathology 23(2-3): 125-135
Bruno, V.; Wroblewska, B.; Wroblewski, J.T.; Fiore, L.; Nicoletti, F. 1998: Neuroprotective activity of N-acetylaspartylglutamate in cultured cortical cells. Neuroscience 85(3): 751-757
Weaver, C.E.; Marek, P.; Park-Chung, M.; Tam, S.W.; Farb, D.H. 1997: Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proceedings of the National Academy of Sciences of the United States of America 94(19): 10450-10454
Forloni, G.; Angeretti, N.; Smiroldo, S. 1994: Neuroprotective activity of acetyl-L-carnitine: studies in vitro. Journal of Neuroscience Research 37(1): 92-96
Coppi, G. 1995: Neuroprotective activity of alpha-dihydroergocryptine in animal models. Journal of Neural Transmission. Supplementum 45: 307-318
Lin, R.C.; Matesic, D.F.; McKenzie, R.J.; Devlin, T.M.; von Lubitz, D.K. 1993: Neuroprotective activity of dimer of 16,16'-dimethyl-15-dehydroprostaglandin B1 (di-Calciphor) in cerebral ischemia. Brain Research 606(1): 130-134
Trimarchi, G.R.; Arcadi, F.A.; De Luca, R.; Imperatore, C.; Santoro, G.; Trimarchi, F.; Costa, G. 1993: Neuroprotective activity of fructose-1,6-bisphosphate following transient forebrain ischemia in the Mongolian gerbil. Japanese Journal of Pharmacology 62(3): 215-222
Maurice, T.; Lockhart, B.P. 1997: Neuroprotective and anti-amnesic potentials of sigma (sigma) receptor ligands. Progress in Neuro-Psychopharmacology and Biological Psychiatry 21(1): 69-102
Eshhar, N.; Striem, S.; Kohen, R.; Tirosh, O.; Biegon, A. 1995: Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. European Journal of Pharmacology 283(1-3): 19-29
Gash, D.M.; Zhang, Z.; Gerhardt, G. 1998: Neuroprotective and neurorestorative properties of GDNF. Annals of Neurology 44(3 Suppl 1): S121-S125
Chen, H.S.; Wang, Y.F.; Rayudu, P.V.; Edgecomb, P.; Neill, J.C.; Segal, M.M.; Lipton, S.A.; Jensen, F.E. 1998: Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86(4): 1121-1132
Kuroda, Y.; Strebel, S.; Rafferty, C.; Bullock, R. 1993: Neuroprotective doses of N-methyl-D-aspartate receptor antagonists profoundly reduce the minimum alveolar anesthetic concentration (MAC) for isoflurane in rats. Anesthesia and Analgesia 77(4): 795-800
Yamamoto, K.; Yoshikawa, R.; Okuyama, S.; Takahashi, Y.; Karasawa, Y.; Hino, N.; Miyoshi, T.; Araki, H.; Hanabusa, K.; Shirai, H.; Tomisawa, K. 1996: Neuroprotective effect of 4'-(4-methylphenyl)-2,2':6',2-terpyridine trihydrochloride, a novel inducer of nerve growth factor. Life Sciences 59(25-26): 2139-2146
Kagami, Y.; Shigenobu, S.; Watanabe, S. 1992: Neuroprotective effect of 5-HT3 receptor antagonist on ischemia-induced decrease in CA1 field potential in rat hippocampal slices. European Journal of Pharmacology 224(1): 51-56
Tokime, T.; Nozaki, K.; Kikuchi, H. 1996: Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neuroscience Letters 206(2-3): 81-84
Levallois, C.; Calvet, M.C.; Petite, D.; Kamenka, J.M. 1994: Neuroprotective effect of N-methyl-D-aspartate non-competitive antagonists (arylcyclohexylamine derivatives) on human cultured spinal cord cells. International Journal of Developmental Neuroscience: the Official Journal of the International Society for Developmental Neuroscience 12(6): 547-555
Yamashita, K.; Kataoka, Y.; Nakashima, M.N.; Yamashita, Y.S.; Tanabe, H.; Araki, H.; Niwa, M.; Taniyama, K. 1996: Neuroprotective effect of TTC-909, an isocarbacyclin methyl ester incorporated in lipid microspheres, on hippocampal delayed neuronal death of stroke-prone spontaneously hypertensive rats. Japanese Journal of Pharmacology 71(4): 351-355
Akiho, H.; Iwai, A.; Tsukamoto, S.; Koshiya, K.; Yamaguchi, T. 1998: Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats. Neuropharmacology 37(2): 159-168
Akiho, H.; Iwai, A.; Katoh-Sudoh, M.; Tsukamoto, S.; Koshiya, K.; Yamaguchi, T. 1998: Neuroprotective effect of YM-39558, orotic acid ethylester, in gerbil forebrain ischemia. Japanese Journal of Pharmacology 76(4): 441-444
Yatsugi, S.; Takahashi, M.; Kawasaki-Yatsugi, S.; Koshiya, K.; Sakamoto, S.; Uematsu, D.; Shimizu-Sasamata, M. 1996: Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 16(5): 959-966
Kawasaki-Yatsugi, S.; Yatsugi, S.; Koshiya, K.; Shimizu-Sasamata, M. 1997: Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats. Japanese Journal of Pharmacology 74(3): 253-260
Cuevas, P.; Revilla, C.; Herreras, O.; Largo, C.; Giménez-Gallego, G. 1994: Neuroprotective effect of acidic fibroblast growth factor on seizure-associated brain damage. Neurological Research 16(5): 365-369
Saito, I.; Asano, T.; Sano, K.; Takakura, K.; Abe, H.; Yoshimoto, T.; Kikuchi, H.; Ohta, T.; Ishibashi, S. 1998: Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 42(2): 269-77; Discussion 277-8
Ikeda, K.; Iwasaki, Y.; Tagaya, N.; Shiojima, T.; Kobayashi, T.; Kinoshita, M. 1995: Neuroprotective effect of basic fibroblast growth factor on wobbler mouse motor neuron disease. Neurological Research 17(6): 445-448
Minamoto, Y.; Tanaka, T.; Shibata, S.; Watanabe, S. 1994: Neuroprotective effect of cholecystokininB receptor antagonist on ischemia-induced decrease in CA1 presynaptic fiber spikes in rat hippocampal slices. Neuroscience Letters 167(1-2): 81-84
Liu, Z.; D'amore, P.A.; Mikati, M.; Gatt, A.; Holmes, G.L. 1993: Neuroprotective effect of chronic infusion of basic fibroblast growth factor on seizure-associated hippocampal damage. Brain Research 626(1-2): 335-338
Hogg, S.; Perron, C.; Barnéoud, P.; Sanger, D.J.; Moser, P.C. 1998: Neuroprotective effect of eliprodil: Attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat. Journal of Neurotrauma 15(7): 545-553
Leib, S.L.; Kim, Y.S.; Ferriero, D.M.; Täuber, M.G. 1996: Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. Journal of Infectious Diseases 173(1): 166-171
Chronopoulos, A.; Stafstrom, C.; Thurber, S.; Hyde, P.; Mikati, M.; Holmes, G.L. 1993: Neuroprotective effect of felbamate after kainic acid-induced status epilepticus. Epilepsia 34(2): 359-366
Willis, C.L.; Meldrum, B.S.; Nunn, P.B.; Anderton, B.H.; Leigh, P.N. 1994: Neuroprotective effect of free radical scavengers on beta-N-oxalylamino-L-alanine (BOAA)-induced neuronal damage in rat hippocampus. Neuroscience Letters 182(2): 159-162
Lukácová, N.; Marsala, M.; Halát, G.; Marsala, J. 1997: Neuroprotective effect of graded postischemic reoxygenation in spinal cord ischemia in the rabbit. Brain Research Bulletin 43(5): 457-465
Perides, G.; Jensen, F.E.; Edgecomb, P.; Rueger, D.C.; Charness, M.E. 1995: Neuroprotective effect of human osteogenic protein-1 in a rat model of cerebral hypoxia/ischemia. Neuroscience Letters 187(1): 21-24
Bruno, V.M.; Goldberg, M.P.; Dugan, L.L.; Giffard, R.G.; Choi, D.W. 1994: Neuroprotective effect of hypothermia in cortical cultures exposed to oxygen-glucose deprivation or excitatory amino acids. Journal of Neurochemistry 63(4): 1398-1406
Sortino, M.A.; Canonico, P.L. 1996: Neuroprotective effect of insulin-like growth factor i in immortalized hypothalamic cells. Endocrinology 137(4): 1418-1422
Fujikawa, D.G. 1995: Neuroprotective effect of ketamine administered after status epilepticus onset. Epilepsia 36(2): 186-195
Lallement, G.; Pierard, C.; Masqueliez, C.; Baubichon, D.; Pernot Marino, I.; Peres, M.; Lagarde, D. 1997: Neuroprotective effect of modafinil against soman-induced hippocampal lesions. Medical Science Research 25(7): 437-440
Huang, R.; Hertz, L. 1995: Neuroprotective effect of phenylsuccinate, an inhibitor of cytosolic glutamate formation from glutamine, under anoxic conditions but not during exposure to exogenous glutamate. Neuroscience Letters 183(1-2): 22-26
Lampley, E.C.; Mishra, O.P.; Graham, E.; Delivoria-Papadopoulos, M. 1995: Neuroprotective effect of phenytoin against in utero hypoxic brain injury in fetal guinea pigs. Neuroscience Letters 186(2-3): 192-196
Shibata, S.; Tominaga, K.; Kagami-ishi, Y.; Watanabe, S. 1992: Neuroprotective effect of protein kinase C inhibitors on oxygen/glucose free-induced decreases in 2-deoxyglucose uptake and CA1 field potentials in rat hippocampal slices. Brain Research 594(2): 290-294
Mackay, K.B.; Bailey, S.J.; King, P.D.; Patel, S.; Hamilton, T.C.; Campbell, C.A. 1996: Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat. Neurodegeneration: a Journal for Neurodegenerative Disorders Neuroprotection and Neuroregeneration 5(4): 319-323
Cascinu, S.; Cordella, L.; Del Ferro, E.; Fronzoni, M.; Catalano, G. 1995: Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 13(1): 26-32
Bannan, P.E.; Graham, D.I.; Lees, K.R.; Mcculloch, J. 1994: Neuroprotective effect of remacemide hydrochloride in focal cerebral ischemia in the cat. Brain Research 664(1-2): 271-275
al-Deeb, S.; al-Moutaery, K.; Bruyn, G.W.; Tariq, M. 1995: Neuroprotective effect of selenium on iminodipropionitrile-induced toxicity. Journal of Psychiatry and Neuroscience: Jpn 20(3): 189-192
Forloni, G.; Lucca, E.; Angeretti, N.; Chiesa, R.; Vezzani, A. 1997: Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: Role of cyclic GMP. Journal of Neurochemistry 68(1): 319-327
Santiago, M.; Matarredona, E.R.; Granero, L.; Cano, J.; Machado, A. 1997: Neuroprotective effect of the iron chelator desferrioxamine against MPP+ toxicity on striatal dopaminergic terminals. Journal of Neurochemistry 68(2): 732-738
Hayward, N.J.; McKnight, A.T.; Woodruff, G.N. 1993: Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia. European Journal of Neuroscience 5(7): 961-967
Ikeda, K.; Iwasaki, Y.; Shiojima, T.; Kinoshita, M. 1996: Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy. Journal of the Neurological Sciences 135(2): 109-113
Meyer, E.M.; King, M.A.; Meyers, C. 1998: Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Research 786(1-2): 252-254
Sun, F.Y.; Faden, A.I. 1995: Neuroprotective effects of 619C89, a use-dependent sodium channel blocker, in rat traumatic brain injury. Brain Research 673(1): 133-140
O'neill, M.J.; Hicks, C.; Ward, M. 1996: Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia. European Journal of Pharmacology 310(2-3): 115-122
Heath, D.L.; Vink, R. 1998: Neuroprotective effects of MgSO4 and MgCl2 in closed head injury: a comparative phosphorus NMR study. Journal of Neurotrauma 15(3): 183-189
Matsuoka, Y.; Kitamura, Y.; Tsukahara, T.; Terai, K.; Tooyama, I.; Kimura, H.; Taniguchi, T. 1995: Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus. Neuroreport 6(16): 2205-2208
Pearlstein, R.D.; Beirne, J.P.; Massey, G.W.; Warner, D.S. 1998: Neuroprotective effects of NMDA receptor glycine recognition site antagonism: Dependence on glycine concentration. Journal of Neurochemistry 70(5): 2012-2019
Gurevich, B.; Artru, A.A.; Lam, A.M.; Mueller, A.L.; Merkind, V.; Talmor, D.; Katchko, L.; Shapira, Y. 1998: Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats. Journal of Neurosurgery 88(6): 1066-1074
Pavlaković, G.; Eyer, C.L.; Isom, G.E. 1995: Neuroprotective effects of PKC inhibition against chemical hypoxia. Brain Research 676(1): 205-211
Boireau, A.; Malgouris, C.; Burgevin, M.C.; Pény, C.; Durand, G.; Bordier, F.; Meunier, M.; Miquet, J.M.; Daniel, M.; Chevet, T.; Jimonet, P.; Mignani, S.; Blanchard, J.C.; Doble, A. 1996: Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro. European Journal of Pharmacology 300(3): 237-246
Small, D.L.; Murray, C.L.; Monette, R.; Kawasaki-Yatsugi, S.; Morley, P. 1998: Neuroprotective effects of a novel AMPA receptor antagonist, YM872. Neuroreport 9(7): 1287-1290
Bond, A.; O'Neill, M.J.; Hicks, C.A.; Monn, J.A.; Lodge, D. 1998: Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia. Neuroreport 9(6): 1191-1193
Graham, S.H.; Chen, J.; Lan, J.; Leach, M.J.; Simon, R.P. 1994: Neuroprotective effects of a use-dependent blocker of voltage-dependent sodium channels, BW619C89, in rat middle cerebral artery occlusion. Journal of Pharmacology and Experimental Therapeutics 269(2): 854-859
Lolic, M.M.; Fiskum, G.; Rosenthal, R.E. 1997: Neuroprotective effects of acetyl-L-carnitine after stroke in rats. Annals of Emergency Medicine 29(6): 758-765
Bernocchi, G.; Gerzeli, G.; Scherini, E.; Vignola, C. 1993: Neuroprotective effects of alpha-dihydroergocryptine against damages in the substantia nigra caused by severe treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Acta Neuropathologica 85(4): 404-413
Wolz, P.; Krieglstein, J. 1996: Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia. Neuropharmacology 35(3): 369-375
Cotter, M.A.; Cameron, N.E. 1995: Neuroprotective effects of carvedilol in diabetic rats: Prevention of defective peripheral nerve perfusion and conduction velocity. Naunyn-Schmiedeberg's Archives of Pharmacology 351(6): 630-635
Lysko, P.G.; Lysko, K.A.; Yue, T.L.; Webb, C.L.; Gu, J.L.; Feuerstein, G. 1992: Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 23(11): 1630-5; Discussion 1635-6
Lysko, P.G.; Webb, C.L.; Feuerstein, G. 1994: Neuroprotective effects of carvedilol, a new antihypertensive, as a Na+ channel modulator and glutamate transport inhibitor. Neuroscience Letters 171(1-2): 77-80
Lysko, P.G.; Lysko, K.A.; Webb, C.L.; Feuerstein, G. 1992: Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor. Neuroscience Letters 148(1-2): 34-38
Nonaka, S.; Chuang, D.M. 1998: Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport 9(9): 2081-2084
Pratt, J.; Roux, M.; Henneguelle, E.; Stutzmann, J.M.; Laduron, P.M. 1994: Neuroprotective effects of colchicine in the gerbil model of cerebral ischaemia. Neuroscience Letters 169(1-2): 114-118
Matthews, R.T.; Yang, L.; Jenkins, B.G.; Ferrante, R.J.; Rosen, B.R.; Kaddurah-Daouk, R.; Beal, M.F. 1998: Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 18(1): 156-163
Kuhmonen, J.; Pokorný, J.; Miettinen, R.; Haapalinna, A.; Jolkkonen, J.; Riekkinen, P.; Sivenius, J. 1997: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 87(2): 371-377
Ying, S.X.; Cheng, J.S. 1995: Neuroprotective effects of dextromethorphan against transient cerebral ischemia/reperfusion injury in gerbils. Zhongguo Yao Li Xue Bao 16(2): 133-136
Kaku, D.A.; Giffard, R.G.; Choi, D.W. 1993: Neuroprotective effects of glutamate antagonists and extracellular acidity. Science 260(5113): 1516-1518
Starcevic, S.L.; Zielinski, B.S. 1997: Neuroprotective effects of glutathione on rainbow trout olfactory receptor neurons during exposure to copper sulfate. Comparative Biochemistry and Physiology C Pharmacology Toxicology and Endocrinology 117(2): 211-219
Loddick, S.A.; Rothwell, N.J. 1996: Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 16(5): 932-940
Zhao, W.; Richardson, J.S.; Mombourquette, M.J.; Weil, J.A.; Ijaz, S.; Shuaib, A. 1996: Neuroprotective effects of hypothermia and U-78517F in cerebral ischemia are due to reducing oxygen-based free radicals: An electron paramagnetic resonance study with gerbils. Journal of Neuroscience Research 45(3): 282-288
Pfenninger, E.; Himmelseher, S. 1997: Neuroprotective effects of ketamine on a cellular level. Anaesthesist 46(Suppl 1): S47-S54
Shuaib, A.; Mahmood, R.H.; Wishart, T.; Kanthan, R.; Murabit, M.A.; Ijaz, S.; Miyashita, H.; Howlett, W. 1995: Neuroprotective effects of lamotrigine in global ischemia in gerbils. A histological, in vivo microdialysis and behavioral study. Brain Research 702(1-2): 199-206
Reddy, D.S.; Kulkarni, S.K. 1997: Neuroprotective effects of neurosteroids against hypoxic-neurotoxicity in naive and benzodiazepine inverse agonist FG 7142-treated mice. Indian Journal of Pharmacology 29(6): 381-392
Small, D.L.; Monette, R.; Mealing, G.; Buchan, A.M.; Morley, P. 1995: Neuroprotective effects of omega-Aga-IVA against in vitro ischaemia in the rat hippocampal slice. Neuroreport 6(12): 1617-1620
Sun, An-Yang 1998: Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats. Acta Pharmacologica Sinica 19(2): 104-108
Marinov, M.B.; Harbaugh, K.S.; Hoopes, P.J.; Pikus, H.J.; Harbaugh, R.E. 1996: Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. Journal of Neurosurgery 85(1): 117-124
Mori, H.; Arai, T.; Ishii, H.; Adachi, T.; Endo, N.; Makino, K.; Mori, K. 1998: Neuroprotective effects of pterin-6-aldehyde in gerbil global brain ischemia: comparison with those of alpha-phenyl-N-tert-butyl nitrone. Neuroscience Letters 241(2-3): 99-102
Couratier, P.; Sindou, P.; Esclaire, F.; Louvel, E.; Hugon, J. 1994: Neuroprotective effects of riluzole in ALS CSF toxicity. Neuroreport 5(8): 1012-1014
Malgouris, C.; Daniel, M.; Doble, A. 1994: Neuroprotective effects of riluzole on N-methyl-D-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neuroscience Letters 177(1-2): 95-99
Barnéoud, P.; Mazadier, M.; Miquet, J.M.; Parmentier, S.; Dubédat, P.; Doble, A.; Boireau, A. 1996: Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat. Neuroscience 74(4): 971-983
Yu, P.H.; Davis, B.A.; Fang, J.; Boulton, A.A. 1994: Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus. Journal of Neurochemistry 63(5): 1820-1828
Sethy, V.H.; Wu, H.; Oostveen, J.A.; Hall, E.D. 1997: Neuroprotective effects of the GABA(A) receptor partial agonist U-101017 in 3-acetylpyridine-treated rats. Neuroscience Letters 228(1): 45-49
O'neill, M.J.; Hicks, C.; Ward, M.; Panetta, J.A. 1997: Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia. Brain Research 760(1-2): 170-178
Hall, E.D.; Andrus, P.K.; Oostveen, J.A.; Althaus, J.S.; VonVoigtlander, P.F. 1996: Neuroprotective effects of the dopamine D2/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Research 742(1-2): 80-88
Sethy, V.H.; Wu, H.; Oostveen, J.A.; Hall, E.D. 1997: Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats. Brain Research 754(1-2): 181-186
Kawaguchi, K.; Graham, S.H. 1997: Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion. Brain Research 749(1): 131-134
Andrus, P.K.; Fleck, T.J.; Oostveen, J.A.; Hall, E.D. 1997: Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons. Journal of Neuroscience Research 47(6): 650-654
Sethy, V.H.; Wu, H.; Oostveen, J.A.; Hall, E.D. 1996: Neuroprotective effects of the pyrrolopyrimidine U-104067F in 3-acetylpyridine-treated rats. Experimental Neurology 140(1): 79-83
Kanthasamy, A.G.; Kanthasamy, A.; Matsumoto, R.R.; Vu, T.Q.; Truong, D.D. 1997: Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist (R)-HA-966 in an experimental model of Parkinson's disease. Brain Research 759(1): 1-8
Carpentier, P.; Foquin, A.; Lallement, G. 1996: Neuroprotective efficacy of TCP in soman poisoning. Travaux Scientifiques des Chercheurs du Service de Sante des Armees 1996(17): 137-138
McBean, D.E.; Winters, V.; Wilson, A.D.; Oswald, C.B.; Alps, B.J.; Armstrong, J.M. 1995: Neuroprotective efficacy of lifarizine (RS-87476) in a simplified rat survival model of 2 vessel occlusion. British Journal of Pharmacology 116(8): 3093-3098
Kohno, K.; Higuchi, T.; Ohta, S.; Kohno, K.; Kumon, Y.; Sakaki, S. 1997: Neuroprotective nitric oxide synthase inhibitor reduces intracellular calcium accumulation following transient global ischemia in the gerbil. Neuroscience Letters 224(1): 17-20
Moosmann, B.; Uhr, M.; Behl, C. 1997: Neuroprotective potential of aromatic alcohols against oxidative cell death. Febs Letters 413(3): 467-472
Satoh, S.; Ikegaki, I.; Suzuki, Y.; Asano, T.; Shibuya, M.; Hidaka, H. 1996: Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils. British Journal of Pharmacology 118(7): 1592-1596
Diop, A.G.; Dussarte, C.; Barthe, D.; Hugon, J. 1996: Neuroprotective properties of calretinin against the HIV-1 gp120 toxicity. Neuroscience Research Communications 18(2): 107-114
Brown, C.M.; Calder, C.; Linton, C.; Small, C.; Kenny, B.A.; Spedding, M.; Patmore, L. 1995: Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia. British Journal of Pharmacology 115(8): 1425-1432
Hall, E.D.; Andrus, P.K.; Fleck, T.J.; Oostveen, J.A.; Carter, D.B.; Jacobsen, E.J. 1997: Neuroprotective properties of the benzodiazepine receptor, partial agonist PNU-101017 in the gerbil forebrain ischemia model. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 17(8): 875-883
Chao, C.C.; Molitor, T.W.; Hu, S. 1993: Neuroprotective role of IL-4 against activated microglia. Journal of Immunology 151(3): 1473-1481
Miguel-Hidalgo, J.J.; Vecino, B.; Fernández-Novoa, L.; Alvarez, A.; Cacabelos, R. 1998: Neuroprotective role of S12024 against neurodegeneration in the rat dentate gyrus. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 8(3): 203-208
Lu, X.C.; Tortella, F.C.; Ved, H.S.; Garcia, G.E.; Dave, J.R. 1997: Neuroprotective role of c-fos antisense oligonucleotide: in vitro and in vivo studies. Neuroreport 8(13): 2925-2929
Klette, K.L.; Lin, Y.; Clapp, L.E.; Decoster, M.A.; Moreton, J.E.; Tortella, F.C. 1997: Neuroprotective sigma ligands attenuate NMDA and trans-ACPD-induced calcium signaling in rat primary neurons. Brain Research 756(1-2): 231-240
Lesage, A.S.; De Loore, K.L.; Peeters, L.; Leysen, J.E. 1995: Neuroprotective sigma ligands interfere with the glutamate-activated NOS pathway in hippocampal cell culture. Synapse 20(2): 156-164
Schulz, J.B.; Matthews, R.T.; Henshaw, D.R.; Beal, M.F. 1996: Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: Implications for neurodegenerative diseases. Neuroscience 71(4): 1043-1048
Rothstein, J.D.; Kuncl, R.W. 1995: Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. Journal of Neurochemistry 65(2): 643-651
Gozes, I.; Bardea, A.; Reshef, A.; Zamostiano, R.; Zhukovsky, S.; Rubinraut, S.; Fridkin, M.; Brenneman, D.E. 1996: Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide. Proceedings of the National Academy of Sciences of the United States of America 93(1): 427-432
McDonald, J.W.; Johnston, M.V. 1992: Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury. Neuroscience Letters 145(2): 213-216
Koller, W.C. 1997: Neuroprotective therapy for Parkinson's disease. Experimental Neurology 144(1): 24-28
Lipton, S.A.; Choi, Y.B.; Sucher, N.J.; Chen, H.S. 1998: Neuroprotective versus neurodestructive effects of NO-related species. Biofactors 8(1-2): 33-40
Sebit, M.B. 1995: Neuropsychiatric HIV-1 infection study: in Kenya and Zaire cross-sectional phase I and II. Central African Journal of Medicine 41(10): 315-322
Hakola, H.P.; Puranen, M. 1993: Neuropsychiatric and brain CT findings in polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Acta Neurologica Scandinavica 88(5): 370-375
Bell, I.R.; Miller, C.S.; Schwartz, G.E.; Peterson, J.M.; Amend, D. 1996: Neuropsychiatric and somatic characteristics of young adults with and without self-reported chemical odor intolerance and chemical sensitivity. Archives of Environmental Health 51(1): 9-21
Diefenbacher, A.; Heim, G. 1997: Neuropsychiatric aspects in Munchausen's syndrome. General Hospital Psychiatry 19(4): 281-285
Veneselli, E.; Biancheri, R.; Perrone, M.V. 1996: Neuropsychiatric aspects in the fragile X syndrome. Giornale di Neuropsichiatria dell'Eta Evolutiva 16(2): 147-154
Cummings, J.L.; Kaufer, D. 1996: Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 47(4): 876-883
Grassi, B.; Garghentini, G.; Gambini, O.; Scarone, S. 1997: Neuropsychiatric aspects of HIV infection: a liaison psychiatry study. European Psychiatry: the Journal of the Association of European Psychiatrists 12(1): 16-20
Riccio, M.; Pugh, K.; Jadresic, D.; Burgess, A.; Thompson, C.; Wilson, B.; Lovett, E.; Baldeweg, T.; Hawkins, D.A.; Catalan, J. 1993: Neuropsychiatric aspects of HIV-1 infection in gay men: Controlled investigation of psychiatric, neuropsychological and neurological status. Journal of Psychosomatic Research 37(8): 819-830
Prasher, V.P.; Barrett, K. 1993: Neuropsychiatric aspects of Sydenham's chorea: a case report. Journal of Psychosomatic Obstetrics and Gynaecology 14(2): 159-162
Moore, D.P. 1996: Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review. Journal of Clinical Psychiatry 57(9): 407-414
Litvan, I.; Mega, M.S.; Cummings, J.L.; Fairbanks, L. 1996: Neuropsychiatric aspects of progressive supranuclear palsy. Neurology 47(5): 1184-1189
Roccella, M.; Vecchio, A. 1998: Neuropsychiatric aspects of the glycosylation deficit syndrome of the glycoproteins (CDG): A new case and review of the literature. Giornale di Neuropsichiatria dell'Eta Evolutiva 18(2): 135-148
Litvan, I.; Paulsen, J.S.; Mega, M.S.; Cummings, J.L. 1998: Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. Archives of Neurology 55(10): 1313-1319
Verhoeven, W.M.A.; Tuinier, S. 1997: Neuropsychiatric consultation in mentally retarded patients: A clinical report. European Psychiatry 12(5): 242-248
Grabow, J.D. 1992: Neuropsychiatric correlates of theta bursts in patients with closed head injury. Brain Injury 6(6): 479-480
Woodbury, M.M.; Woodbury, M.A. 1993: Neuropsychiatric development: two case reports about the use of dietary fish oils and/or choline supplementation in children. Journal of the American College of Nutrition 12(3): 239-245
Spezialetti, R.; Bluestein, H.G.; Peter, J.B.; Alexander, E.L. 1993: Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies. American Journal of Medicine 95(2): 153-160
Lietha, R.; Zimmermann, M. 1994: Neuropsychiatric disorders associated with functional folate deficiency in the presence of elevated serum and erythrocyte folate: A preliminary report. Journal of Nutritional Medicine 4(4): 441-447
Cohen, D.J.; Leckman, J.F.; Pauls, D. 1997: Neuropsychiatric disorders of childhood: Tourette's syndrome as a model. Acta Paediatrica . Supplement 422: 106-111
Lauterbach, E.C.; Spears, T.E.; Prewett, M.J.; Price, S.T.; Jackson, J.G.; Kirsh, A.D. 1994: Neuropsychiatric disorders, myoclonus, and dystonia in calcification of basal ganglia pathways. Biological Psychiatry 35(5): 345-351
Su, T.P.; Pagliaro, M.; Schmidt, P.J.; Pickar, D.; Wolkowitz, O.; Rubinow, D.R. 1993: Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 269(21): 2760-2764
Hirono, N.; Mori, E.; Imamura, T.; Shimomura, T.; Hashimoto, M. 1998: Neuropsychiatric features in Dementia with Lewy bodies and Alzheimer's disease. No to Shinkei 50(1): 45-49
Yaffe, K.; Ettinger, B.; Pressman, A.; Seeley, D.; Whooley, M.; Schaefer, C.; Cummings, S. 1998: Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study. Biological Psychiatry 43(9): 694-700
Lundberg, I.; Michélsen, H.; Nise, G.; Hogstedt, C.; Högberg, M.; Alfredsson, L.; Almkvist, O.; Gustavsson, A.; Hagman, M.; Herlofson, J. 1995: Neuropsychiatric function of housepainters with previous long-term heavy exposure to organic solvents. Scandinavian Journal of Work Environment and Health 21(Suppl): 1-44
Stein, D.J.; Hollander, E.; Cohen, L.; Frenkel, M.; Saoud, J.B.; Decaria, C.; Aronowitz, B.; Levin, A.; Liebowitz, M.R.; Cohen, L. 1993: Neuropsychiatric impairment in impulsive personality disorders. Psychiatry Research 48(3): 257-266
Dennis, M. 1994: Neuropsychiatric lupus erythematosus and the elderly. International Journal of Geriatric Psychiatry 9(2): 97-106
West, S.G.; Emlen, W.; Wener, M.H.; Kotzin, B.L. 1995: Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. American Journal of Medicine 99(2): 153-163
Sillevis Smitt, P.; Swaak, T. 1998: Neuropsychiatric lupus?. Annals of the Rheumatic Diseases 57(1): 9-10
Rønn, A.M.; Rønne-Rasmussen, J.; Gøtzsche, P.C.; Bygbjerg, I.C. 1998: Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Tropical Medicine and International Health: Tm and Ih 3(2): 83-88
Watanabe, T.; Sato, T.; Uchiumi, T.; Arakawa, M. 1996: Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody. Lupus 5(3): 178-183
Paparone, P.W. 1998: Neuropsychiatric manifestations of Lyme disease. Journal of the American Osteopathic Association 98(7): 373-378
Krieger, S.; Jauss, M.; Jansen, O.; Theilmann, L.; Geissler, M.; Krieger, D. 1996: Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111(1): 147-155
Jaeger, J.; Douglas, E. 1992: Neuropsychiatric rehabilitation for persistent mental illness. Psychiatric Quarterly 63(1): 71-94
Krasuski, J.S.; Gaviria, M. 1994: Neuropsychiatric sequelae of ischaemic cerebrovascular disease: clinical and neuroanatomic correlates and implications for the concept of dementia. Neurological Research 16(4): 241-250
Otte, A.; Weiner, S.M.; Hoegerle, S.; Wolf, R.; Juengling, F.D.; Peter, H.H.; Nitzsche, E.U. 1998: Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 7(1): 57-59
Dennis, M.S.; Byrne, E.J.; Hopkinson, N.; Bendall, P. 1992: Neuropsychiatric systemic lupus erythematosus in elderly people: A case series. Journal of Neurology Neurosurgery and Psychiatry 55(12): 1157-1161
Simpson, S.; Baldwin, B. 1995: Neuropsychiatry and SPECT of an acute obsessive-compulsive syndrome patient. British Journal of Psychiatry: the Journal of Mental Science 166(3): 390-392
Weitzner, M.A. 1998: Neuropsychiatry and pituitary disease: an overview. PsychoTherapy and Psychosomatics 67(3): 125-132
Yang, Zuo Lian 1994: Neuropsychic disturbances in patients with islet cell tumors. Zhong Guo Zhong Liu Lin Chuang 21(8): 595-597
Jovic, N.; Milovanovic, V.; Knezevic, L. 1996: Neuropsychologic analysis of children with ticks. Psihijatrija Danas 28(4): 397-422
Sipinen, S.A.; Kulvik, M.; Leiniö, M.; Viljanen, A.; Lindholm, H. 1995: Neuropsychologic and cardiovascular effects of clemastine fumarate under pressure. Undersea and Hyperbaric Medicine: Journal of the Undersea and Hyperbaric Medical Society Inc 22(4): 401-406
Weaver, L.K.; Hopkins, R.O.; Larson-Lohr, V. 1996: Neuropsychologic and functional recovery from severe carbon monoxide poisoning without hyperbaric oxygen therapy. Annals of Emergency Medicine 27(6): 736-740
Kneebone, A.C.; Andrew, M.J.; Baker, R.A.; Knight, J.L. 1998: Neuropsychologic changes after coronary artery bypass grafting: Use of reliable change indices. Annals of Thoracic Surgery 65(5): 1320-1325
Schmidt, R.; Fazekas, F.; Offenbacher, H.; Dusek, T.; Zach, E.; Reinhart, B.; Grieshofer, P.; Freidl, W.; Eber, B.; Schumacher, M. 1993: Neuropsychologic correlates of MRi white matter hyperintensities: a study of 150 normal volunteers. Neurology 43(12): 2490-2494
Goldberg, M.B.; Mock, D.; Ichise, M.; Proulx, G.; Gordon, A.; Shandling, M.; Tsai, S.; Tenenbaum, H.C. 1996: Neuropsychologic deficits and clinical features of posttraumatic temporomandibular disorders. Journal of Orofacial Pain 10(2): 126-140
Meltzer, H.Y.; Thompson, P.A.; Lee, M.A.; Ranjan, R. 1996: Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 14(3 Suppl): 27s-33s
Derksen-Lubsen, G.; Verkerk, P.H. 1996: Neuropsychologic development in early treated congenital hypothyroidism: analysis of literature data. Pediatric Research 39(3): 561-566
Varney, N.R.; Syrop, C.; Kubu, C.S.; Struchen, M.; Hahn, S.; Franzen, K. 1993: Neuropsychologic dysfunction in women following leuprolide acetate induction of hypoestrogenism. Journal of Assisted Reproduction and Genetics 10(1): 53-57
Antonelli Incalzi, R.; Gemma, A.; Landi, F.; Pagano, F.; Capparella, O.; Snider, F.; Manni, R.; Carbonin, P. 1997: Neuropsychologic effects of carotid endarterectomy. Journal of Clinical and Experimental Neuropsychology 19(6): 785-794
Copeland, D.R.; Moore, B.D.; Francis, D.J.; Jaffe, N.; Culbert, S.J. 1996: Neuropsychologic effects of chemotherapy on children with cancer: a longitudinal study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(10): 2826-2835
Butler, R.W.; Hill, J.M.; Steinherz, P.G.; Meyers, P.A.; Finlay, J.L. 1994: Neuropsychologic effects of cranial irradiation, intrathecal methotrexate, and systemic methotrexate in childhood cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(12): 2621-2629
Kocsis, J.H.; Shaw, E.D.; Stokes, P.E.; Wilner, P.; Elliot, A.S.; Sikes, C.; Myers, B.; Manevitz, A.; Parides, M. 1993: Neuropsychologic effects of lithium discontinuation. Journal of Clinical Psychopharmacology 13(4): 268-275
Craft, S.; Schatz, J.; Glauser, T.A.; Lee, B.; Debaun, M.R. 1993: Neuropsychologic effects of stroke in children with sickle cell anemia. Journal of Pediatrics 123(5): 712-717
Dennis, M.; Barnes, M.A. 1994: Neuropsychologic function in same-sex twins discordant for perinatal brain damage. Journal of Developmental and Behavioral Pediatrics: Jdbp 15(2): 124-130
Whitt, J.K.; Hooper, S.R.; Tennison, M.B.; Robertson, W.T.; Gold, S.H.; Burchinal, M.; Wells, R.; McMillan, C.; Whaley, R.A.; Combest, J. 1993: Neuropsychologic functioning of human immunodeficiency virus-infected children with hemophilia. Journal of Pediatrics 122(1): 52-59
Mulhern, R.K.; Kepner, J.L.; Thomas, P.R.; Armstrong, F.D.; Friedman, H.S.; Kun, L.E. 1998: Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(5): 1723-1728
Burgard, P.; Rey, F.; Rupp, A.; Abadie, V.; Rey, J. 1997: Neuropsychologic functions of early treated patients with phenylketonuria, on and off diet: results of a cross-national and cross-sectional study. Pediatric Research 41(3): 368-374
Andrykowski, M.A.; Schmitt, F.A.; Gregg, M.E.; Brady, M.J.; Lamb, D.G.; Henslee-Downey, P.J. 1992: Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 70(9): 2288-2297
Albert, S.M.; Marder, K.; Dooneief, G.; Bell, K.; Sano, M.; Todak, G.; Stern, Y. 1995: Neuropsychologic impairment in early HIV infection. A risk factor for work disability. Archives of Neurology 52(5): 525-530
Roshchina, I.F.; Zharikov, G.A. 1998: Neuropsychologic method in diagnosis of mild dementia in elderly and senile patients. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 98(2): 34-40
Marson, D.C.; Cody, H.A.; Ingram, K.K.; Harrell, L.E. 1995: Neuropsychologic predictors of competency in Alzheimer's disease using a rational reasons legal standard. Archives of Neurology 52(10): 955-959
Lenti, C.; Campetella, S.; Narcisi, R.; Dieci, M. 1994: Neuropsychologic study of epileptic children. Giornale di Neuropsichiatria dell'Eta Evolutiva 14(2): 87-95
Tuokko, H.; Kristjansson, E.; Miller, J. 1995: Neuropsychological detection of dementia: an overview of the neuropsychological component of the Canadian Study of Health and Aging. Journal of Clinical and Experimental Neuropsychology 17(3): 352-373
Roehrs, T.; Merrion, M.; Pedrosi, B.; Stepanski, E.; Zorick, F.; Roth, T. 1995: Neuropsychological function in obstructive sleep apnea syndrome (OSAS) compared to chronic obstructive pulmonary disease (COPD). Sleep 18(5): 382-388
Villa, G.; Monteleone, D.; Marra, C.; Bartoli, A.; Antinori, A.; Pallavicini, F.; Tamburrini, E.; Izzi, I. 1993: Neuropsychological abnormalities in AIDS and asymptomatic HIV seropositive patients. Journal of Neurology Neurosurgery and Psychiatry 56(8): 878-884
Grattan-Smith, P.J.; Morris, J.G.; Shores, E.A.; Batchelor, J.; Sparks, R.S. 1992: Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurologica Scandinavica 86(6): 626-631
López-Villegas, D.; Kulisevsky, J.; Deus, J.; Junqué, C.; Pujol, J.; Guardia, E.; Grau, J.M. 1996: Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification. Archives of Neurology 53(3): 251-256
Semenovich, A.V.; Umrikhin, S.O.; Tsyganok, A.A. 1992: Neuropsychological analysis of poor academic performance among public school students. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 42(4): 655-663
Fischer, R.S.; Alexander, M.P.; D'Esposito, M.; Otto, R. 1995: Neuropsychological and neuroanatomical correlates of confabulation. Journal of Clinical and Experimental Neuropsychology 17(1): 20-28
Evans, J.; Wilson, B.; Wraight, E.P.; Hodges, J.R. 1993: Neuropsychological and SPECT scan findings during and after transient global amnesia: evidence for the differential impairment of remote episodic memory. Journal of Neurology Neurosurgery and Psychiatry 56(11): 1227-1230
Mariani, M.A.; Barkley, R.A. 1997: Neuropsychological and academic functioning in preschool boys with attention deficit hyperactivity disorder. Developmental Neuropsychology 13(1): 111-129
Bender, B.G.; Iklé, D.N.; DuHamel, T.; Tinkelman, D. 1998: Neuropsychological and behavioral changes in asthmatic children treated with beclomethasone dipropionate versus theophylline. Pediatrics 101(3 Pt 1): 355-360
Trefz, F.; de Sonneville, L.; Matthis, P.; Benninger, C.; Lanz-Englert, B.; Bickel, H. 1994: Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Human Genetics 93(4): 369-374
Barratt, E.S.; Stanford, M.S.; Kent, T.A.; Felthous, A. 1997: Neuropsychological and cognitive psychophysiological substrates of impulsive aggression. Biological Psychiatry 41(10): 1045-1061
Saccomani, L.; Battaglia, F.M.; Rizzo, P.; Ravera, G.; Trompetto, G.; De Negri, M. 1995: Neuropsychological and interactive aspects in children with ADDH resulting from multiple causes. Giornale di Neuropsichiatria dell'Eta Evolutiva 15(2): 111-120
Goodwin, G.M. 1997: Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. Journal of Psychopharmacology 11(2): 115-122
Christie, D.; Battin, M.; Leiper, A.D.; Chessells, J.; Vargha-Khadem, F.; Neville, B.G. 1994: Neuropsychological and neurological outcome after relapse of lymphoblastic leukaemia. Archives of Disease in Childhood 70(4): 275-280
Caraceni, A.; Martini, C.; Belli, F.; Mascheroni, L.; Rivoltini, L.; Arienti, F.; Cascinelli, N. 1993: Neuropsychological and neurophysiological assessment of the central effects of interleukin-2 administration. European Journal of Cancer 29a(9): 1266-1269
Lincoln, A.J.; Bloom, D.; Katz, M.; Boksenbaum, N. 1998: Neuropsychological and neurophysiological indices of auditory processing impairment in children with multiple complex developmental disorder. Journal of the American Academy of Child and Adolescent Psychiatry 37(1): 100-112
Starkstein, S.E.; Federoff, J.P.; Price, T.R.; Leiguarda, R.C.; Robinson, R.G. 1994: Neuropsychological and neuroradiologic correlates of emotional prosody comprehension. Neurology 44(3 Part 1): 515-522
Lenti, C.; Bianchini, E. 1993: Neuropsychological and neuroradiological study of a case of early-onset Huntington's chorea. Developmental Medicine and Child Neurology 35(11): 1007-1010
Pantelis, C.; Brewer, W. 1995: Neuropsychological and olfactory dysfunction in schizophrenia: Relationship of frontal syndromes to syndromes of schizophrenia. Schizophrenia Research 17(1): 35-45
Starkstein, S.E.; Sabe, L.; Petracca, G.; Chemerinski, E.; Kuzis, G.; Merello, M.; Leiguarda, R. 1996: Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia. Journal of Neurology Neurosurgery and Psychiatry 61(4): 381-387
Saint-Cyr, J.A.; Taylor, A.E.; Lang, A.E. 1993: Neuropsychological and psychiatric side effects in the treatment of Parkinson's disease. Neurology 43(12 Suppl 6): S47-S52
Brekke, J.S.; Raine, A.; Ansel, M.; Lencz, T.; Bird, L. 1997: Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia. Schizophrenia Bulletin 23(1): 19-28
Miotto, E.C. 1994: Neuropsychological approach of the frontal lobes. Revista ABP-APAL (Associacao Brasileira de Psiquiatria-Asociacion Psiquiatrica de la America Latina) 16(2): 52-56
Fiedler, N. 1996: Neuropsychological approaches for the detection and evaluation of toxic symptoms. Environmental Health Perspectives 104(Suppl): 239-245
Lannoo, E.; De Paepe, A.; Leroy, B.; Thiery, E. 1996: Neuropsychological aspects of Marfan syndrome. Clinical Genetics 49(2): 65-69
Ghaemi, S.N.; Hebben, N.; Stoll, A.L.; Pope, H.G. 1996: Neuropsychological aspects of lack of insight in bipolar disorder: A preliminary report. Psychiatry Research 65(2): 113-120
Wishart, H.; Sharpe, D. 1997: Neuropsychological aspects of multiple sclerosis: a quantitative review. Journal of Clinical and Experimental Neuropsychology 19(6): 810-824
Mcmillan, T.M. 1997: Neuropsychological assessment after extremely severe head injury in a case of life or death. Brain Injury 11(7): 483-490
Leroy, A.; Michelet, D.; Mahieux, F.; Geny, C.; Defer, G.; Monfort, J.C.; Degos, J.D.; N'guyen, J.P.; Peschanski, M.; Cesaro, P. 1996: Neuropsychological testing of 5 patients with Parkinson's disease before and after neuron graft. Revue Neurologique (Paris) 152(3): 158-164
Schantz, S.L.; Sweeney, A.M.; Gardiner, J.C.; Humphrey, H.E.; McCaffrey, R.J.; Gasior, D.M.; Srikanth, K.R.; Budd, M.L. 1996: Neuropsychological assessment of an aging population of Great Lakes fisheaters. Toxicology and Industrial Health 12(3-4): 403-417
Mirsky, A.F.; Ingraham, L.J.; Kugelmass, S. 1995: Neuropsychological assessment of attention and its pathology in the Israeli cohort. Schizophrenia Bulletin 21(2): 193-204
Rugle, L.; Melamed, L. 1993: Neuropsychological assessment of attention problems in pathological gamblers. Journal of Nervous and Mental Disease 181(2): 107-112
Tondi, M.; Tola, G.; Maggetti, S.; Mastropaolo, C. 1992: Neuropsychological assessment of children and adolescents newly treated with sodium valproate. Giornale di Neuropsichiatria dell'Eta Evolutiva 12(4): 313-323
Wyckoff, P.M.; Miller, L.C.; Tucker, L.B.; Schaller, J.G. 1995: Neuropsychological assessment of children and adolescents with systemic lupus erythematosus. Lupus 4(3): 217-220
Almkvist, O.; Bråne, G.; Johanson, A. 1996: Neuropsychological assessment of dementia: State of the art. Acta Neurologica Scandinavica. Supplementum 168: 45-49
Nell, V.; Myers, J.; Colvin, M.; Rees, D. 1993: Neuropsychological assessment of organic solvent effects in South Africa: test selection, adaptation, scoring, and validation issues. Environmental Research 63(2): 301-318
Cantor-Graae, E.; Warkentin, S.; Nilsson, A. 1995: Neuropsychological assessment of schizophrenic patients during a psychotic episode: persistent cognitive deficit?. Acta Psychiatrica Scandinavica 91(4): 283-288
Peavy, G.M.; Salmon, D.P.; Rice, V.A.; Galasko, D.; Samuel, W.; Taylor, K.I.; Ernesto, C.; Butters, N.; Thal, L. 1996: Neuropsychological assessment of severely demeted elderly: the severe cognitive impairment profile. Archives of Neurology 53(4): 367-372
Retzlaff, P.; Butler, M.; Vanderploeg, R.D. 1992: Neuropsychological battery choice and theoretical orientation: A multivariate analysis. Journal of Clinical Psychology 48(5): 666-672
Tönne, U.; Hiltunen, A.J.; Vikander, B.; Engelbrektsson, K.; Bergman, H.; Bergman, I.; Leifman, H.; Borg, S. 1995: Neuropsychological changes during steady-state drug use, withdrawal and abstinence in primary benzodiazepine-dependent patients. Acta Psychiatrica Scandinavica 91(5): 299-304
Stern, Y.; Liu, X.; Marder, K.; Todak, G.; Sano, M.; Ehrhardt, A.; Gorman, J. 1995: Neuropsychological changes in a prospectively followed cohort of homosexual and bisexual men with and without HIV infection. Neurology 45(3 Pt 1): 467-472
Díaz-Olavarrieta, C.; Ostrosky-Solis, F.; Garcia de la Cadena, C.; Rodriguez, Y.; Alonso, E. 1997: Neuropsychological changes in subjects at risk of inheriting Alzheimer's disease. Neuroreport 8(11): 2449-2453
Godefroy, O.; Rousseaux, M.; Pruvo, J.P.; Cabaret, M.; Leys, D. 1994: Neuropsychological changes related to unilateral lenticulostriate infarcts. Journal of Neurology Neurosurgery and Psychiatry 57(4): 480-485
Rosenberg, N.K.; Sørensen, S.A.; Christensen, A.L. 1995: Neuropsychological characteristics of Huntington's disease carriers: a double blind study. Journal of Medical Genetics 32(8): 600-604
Brookshire, B.L.; Butler, I.J.; Ewing-Cobbs, L.; Fletcher, J.M. 1994: Neuropsychological characteristics of children with Tourette syndrome: evidence for a nonverbal learning disability?. Journal of Clinical and Experimental Neuropsychology 16(2): 289-302
Finali, G.; Piccirilli, M.; Rizzuto, S. 1995: Neuropsychological characteristics of parkinsonian patients with lateralized motor impairment. Journal of Neural Transmission. Parkinson's Disease and Dementia Section 9(2-3): 165-176
Jacobs, D.M.; Marder, K.; Côté, L.J.; Sano, M.; Stern, Y.; Mayeux, R. 1995: Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 45(9): 1691-1696
Hermann, B.P.; Seidenberg, M.; Schoenfeld, J.; Davies, K. 1997: Neuropsychological characteristics of the syndrome of mesial temporal lobe epilepsy. Archives of Neurology 54(4): 369-376
McCrea, M.; Cordoba, J.; Vessey, G.; Blei, A.T.; Randolph, C. 1996: Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology 53(8): 758-763
Maruff, P.; Currie, J.; Malone, V.; McArthur-Jackson, C.; Mulhall, B.; Benson, E. 1994: Neuropsychological characterization of the AIDS dementia complex and rationalization of a test battery. Archives of Neurology 51(7): 689-695
Muldoon, M.F.; Waldstein, S.R.; Jennings, J.R. 1995: Neuropsychological consequences of antihypertensive medication use. Experimental Aging Research 21(4): 353-368
Trépanier, L.L.; Saint-Cyr, J.A.; Lozano, A.M.; Lang, A.E. 1998: Neuropsychological consequences of posteroventral pallidotomy for the treatment of Parkinson's disease. Neurology 51(1): 207-215
Kaprinis, G.; Tzavaras, A. 1993: Neuropsychological consequences of the exposure of a group of telephonists to unusual auditory stimuli. Perceptual and Motor Skills 76(3 Part 1): 775-782
Wilson, J.T.; Hadley, D.M.; Wiedmann, K.D.; Teasdale, G.M. 1995: Neuropsychological consequences of two patterns of brain damage shown by MRi in survivors of severe head injury. Journal of Neurology Neurosurgery and Psychiatry 59(3): 328-331
Korkman, M.; Liikanen, A.; Fellman, V. 1996: Neuropsychological consequences of very low birth weight and asphyxia at term: follow-up until school-age. Journal of Clinical and Experimental Neuropsychology 18(2): 220-233
Kettlewell, N.; Lipscomb, S. 1992: Neuropsychological correlates for realism-abstraction, a dimension of aesthetics. Perceptual and Motor Skills 75(3 Part 1): 1023-1026
Finali, G.; Piccirilli, M.; Piccinin, G.L. 1994: Neuropsychological correlates of L-deprenyl therapy in idiopathic parkinsonism. Progress in Neuro-Psychopharmacology and Biological Psychiatry 18(1): 115-128
Nestor, P.G.; Shenton, M.E.; McCarley, R.W.; Haimson, J.; Smith, R.S.; O'Donnell, B.; Kimble, M.; Kikinis, R.; Jolesz, F.A. 1993: Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. American Journal of Psychiatry 150(12): 1849-1855
Stolar, N.; Berenbaum, H.; Banich, M.T.; Barch, D. 1994: Neuropsychological correlates of alogia and affective flattening in schizophrenia. Biological Psychiatry 35(3): 164-172
Starkstein, S.E.; Brandt, J.; Bylsma, F.; Peyser, C.; Folstein, M.; Folstein, S.E. 1992: Neuropsychological correlates of brain atrophy in Huntington's disease: A magnetic resonance imaging study. Neuroradiology 34(6): 487-489
Kahn, R.S.; Harvey, P.D.; Davidson, M.; Keefe, R.S.; Apter, S.; Neale, J.M.; Mohs, R.C.; Davis, K.L. 1994: Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. Schizophrenia Research 11(3): 217-224
Nigg, J.T.; Hinshaw, S.P.; Carte, E.T.; Treuting, J.J. 1998: Neuropsychological correlates of childhood attention-deficit/hyperactivity disorder: explainable by comorbid disruptive behavior or reading problems?. Journal of Abnormal Psychology 107(3): 468-480
Nyman, H.; Mindus, P. 1995: Neuropsychological correlates of intractable anxiety disorder before and after capsulotomy. Acta Psychiatrica Scandinavica 91(1): 23-31
Stiles, K.M.; Bellinger, D.C. 1993: Neuropsychological correlates of low-level lead exposure in school-age children: A prospective study. Neurotoxicology and Teratology 15(1): 27-35
Basso, M.R.; Nasrallah, H.A.; Olson, S.C.; Bornstein, R.A. 1998: Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia Research 31(2-3): 99-111
Zakzanis, K.K. 1998: Neuropsychological correlates of positive vs. negative schizophrenic symptomatology. Schizophrenia Research 29(3): 227-233
Chen, E.Y.; Lam, L.C.; Chen, R.Y.; Nguyen, D.G.; Chan, C.K.; Wilkins, A.J. 1997: Neuropsychological correlates of sustained attention in schizophrenia. Schizophrenia Research 24(3): 299-310
Easton, C.; Bauer, L.O. 1996: Neuropsychological correlates of urine toxicology results. Progress in Neuro-Psychopharmacology and Biological Psychiatry 20(6): 969-982
Lapierre, D.; Braun, C.M.; Hodgins, S.; Toupin, J.; Léveillée, S.; Constantineau, C. 1995: Neuropsychological correlates of violence in schizophrenia. Schizophrenia Bulletin 21(2): 253-262
Bast-Pettersen, R.; Drabløs, P.A.; Goffeng, L.O.; Thomassen, Y.; Torres, C.G. 1994: Neuropsychological deficit among elderly workers in aluminum production. American Journal of Industrial Medicine 25(5): 649-662
Foster, H.G.; Hillbrand, M.; Silverstein, M. 1993: Neuropsychological deficit and aggressive behavior: A prospective study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 17(6): 939-946
Rubin, P.; Holm, A.; Møller-Madsen, S.; Videbech, P.; Hertel, C.; Povlsen, U.J.; Hemmingsen, R. 1995: Neuropsychological deficit in newly diagnosed patients with schizophrenia or schizophreniform disorder. Acta Psychiatrica Scandinavica 92(1): 35-43
Palmer, B.W.; Boone, K.B.; Lesser, I.M.; Wohl, M.A.; Berman, N.; Miller, B.L. 1996: Neuropsychological deficits among older depressed patients with predominantly psychological or vegetative symptoms. Journal of Affective Disorders 41(1): 17-24
Adams, K.M.; Gilman, S.; Koeppe, R.A.; Kluin, K.J.; Brunberg, J.A.; Dede, D.; Berent, S.; Kroll, P.D. 1993: Neuropsychological deficits are correlated with frontal hypometabolism in positron emission tomography studies of older alcoholic patients. Alcoholism Clinical and Experimental Research 17(2): 205-210
Baxter, R.D.; Liddle, P.F. 1998: Neuropsychological deficits associated with schizophrenic syndromes. Schizophrenia Research 30(3): 239-249
Maddocks, D.; Saling, M. 1996: Neuropsychological deficits following concussion. Brain Injury 10(2): 99-103
Hestad, K.; Aukrust, P.; Ellertsen, B.; Kløve, H.; Wilberg, K. 1993: Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. Journal of Clinical and Experimental Neuropsychology 15(5): 732-742
Berry, J.; van Gorp, W.G.; Herzberg, D.S.; Hinkin, C.; Boone, K.; Steinman, L.; Wilkins, J.N. 1993: Neuropsychological deficits in abstinent cocaine abusers: preliminary findings after two weeks of abstinence. Drug and Alcohol Dependence 32(3): 231-237
Zöller, M.E.; Rembeck, B.; Bäckman, L. 1997: Neuropsychological deficits in adults with neurofibromatosis type 1. Acta Neurologica Scandinavica 95(4): 225-232
Farina, E.; Magni, E.; Ambrosini, F.; Manfredini, R.; Binda, A.; Sina, C.; Mariani, C. 1997: Neuropsychological deficits in asymptomatic atrial fibrillation. Acta Neurologica Scandinavica 96(5): 310-316
Foong, J.; Rozewicz, L.; Quaghebeur, G.; Thompson, A.J.; Miller, D.H.; Ron, M.A. 1998: Neuropsychological deficits in multiple sclerosis after acute relapse. Journal of Neurology Neurosurgery and Psychiatry 64(4): 529-532
Saykin, A.J.; Shtasel, D.L.; Gur, R.E.; Kester, D.B.; Mozley, L.H.; Stafiniak, P.; Gur, R.C. 1994: Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry 51(2): 124-131
Purcell, R.; Maruff, P.; Kyrios, M.; Pantelis, C. 1998: Neuropsychological deficits in obsessive-compulsive disorder: a comparison with unipolar depression, panic disorder, and normal controls. Archives of General Psychiatry 55(5): 415-423
Weissenborn, K.; Rückert, N.; Ehrenheim, C.; Schellong, S.; Goetz, C.; Lubach, D. 1996: Neuropsychological deficits in patients with Sneddon's syndrome. Journal of Neurology 243(4): 357-363
Sautter, F.J.; Mcdermott, B.E.; Cornwell, J.; Wilson, A.F.; Johnson, J.; Vasterling, J.J. 1997: Neuropsychological deficits in probands from multiply-affected schizophrenic families. Journal of Psychiatric Research 31(5): 497-508
Kertesz, A.; Clydesdale, S. 1994: Neuropsychological deficits in vascular dementia vs Alzheimer's disease. Frontal lobe deficits prominent in vascular dementia. Archives of Neurology 51(12): 1226-1231
Smedler, A.C.; Bolme, P. 1995: Neuropsychological deficits in very young bone marrow transplant recipients. Acta Paediatrica 84(4): 429-433
Jacobs, D.M.; Sano, M.; Dooneief, G.; Marder, K.; Bell, K.L.; Stern, Y. 1995: Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 45(5): 957-962
Bargagna, S.; Chiovato, L.; Dinetti, D.; Montanelli, L.; Giachetti, C.; Romolini, E.; Marcheschi, M.; Pinchera, A. 1997: Neuropsychological development in a child with early-treated congenital hypothyroidism as compared with her unaffected identical twin. European Journal of Endocrinology 136(1): 100-104
Roztocil, A.; Bendova, M.; Elstnerova, L.; Pilka, L. 1993: Neuropsychological development of children and the state of family relations after a successful in vitro fertilization. Scripta Medica 66(1-2): 35-39
Easton, C.; Bauer, L.O. 1997: Neuropsychological differences between alcohol-dependent and cocaine-dependent patients with or without problematic drinking. Psychiatry Research 71(2): 97-103
Goldstein, G.; Beers, S.R.; Shemansky, W.J. 1996: Neuropsychological differences between schizophrenic patients with heterogeneous Wisconsin card sorting test performance. Schizophrenia Research 21(1): 13-18
Walzer, T.; Herrmann, M.; Wallesch, C.W. 1997: Neuropsychological disorders after coronary bypass surgery. Journal of Neurology Neurosurgery and Psychiatry 62(6): 644-648
Camus, J.F.; Turpin, J.C.; Legrand, C. 1997: Neuropsychological disorders in Huntington's disease. Study protocol and preliminary findings. Semaine des Hopitaux 73(15-16): 469-476
Aronson, M.; Hagberg, B. 1998: Neuropsychological disorders in children exposed to alcohol during pregnancy: a follow-up study of 24 children to alcoholic mothers in Göteborg, Sweden. Alcoholism Clinical and Experimental Research 22(2): 321-324
Korteling, J.E.; Kaptein, N.A. 1996: Neuropsychological driving fitness tests for brain-damaged subjects. Archives of Physical Medicine and Rehabilitation 77(2): 138-146
Harris, J.G.; Adler, L.E.; Young, D.A.; Cullum, C.M.; Rilling, L.M.; Cicerello, A.; Intemann, P.M.; Freedman, R. 1996: Neuropsychological dysfunction in parents of schizophrenics. Schizophrenia Research 20(3): 253-260
Voglmaier, M.M.; Seidman, L.J.; Salisbury, D.; McCarley, R.W. 1997: Neuropsychological dysfunction in schizotypal personality disorder: A profile analysis. Biological Psychiatry 41(5): 530-540
Szabó, C.A.; Wyllie, E.; Stanford, L.D.; Geckler, C.; Kotagal, P.; Comair, Y.G.; Thornton, A.E. 1998: Neuropsychological effect of temporal lobe resection in preadolescent children with epilepsy. Epilepsia 39(8): 814-819
Fleming, K.; Bigelow, L.B.; Weinberger, D.R.; Goldberg, T.E. 1995: Neuropsychological effects of amphetamine may correlate with personality characteristics. Psychopharmacology Bulletin 31(2): 357-362
Nichols, M.E.; Meador, K.J.; Loring, D.W. 1993: Neuropsychological effects of antiepileptic drugs: a current perspective. Clinical Neuropharmacology 16(6): 471-484
Butler, R.W.; Copeland, D.R. 1993: Neuropsychological effects of central nervous system prophylactic treatment in childhood leukemia: methodological considerations. Journal of Pediatric Psychology 18(3): 319-338
Peper, M.; Klett, M.; Frentzel-Beyme, R.; Heller, W.D. 1993: Neuropsychological effects of chronic exposure to environmental dioxins and furans. Environmental Research 60(1): 124-135
Roman, D.D.; Sperduto, P.W. 1995: Neuropsychological effects of cranial radiation: current knowledge and future directions. International Journal of Radiation Oncology Biology Physics 31(4): 983-998
White, R.F.; Robins, T.G.; Proctor, S.; Echeverria, D.; Rocskay, A.S. 1994: Neuropsychological effects of exposure to naphtha among automotive workers. Occupational and Environmental Medicine 51(2): 102-112
Griffiths, P.; Paterson, L.; Harvie, A. 1995: Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria. Journal of Intellectual Disability Research: Jidr 39: 365-372
Glenn, S.W.; Parsons, O.A. 1992: Neuropsychological efficiency measures in male and female alcoholics. Journal of Studies on Alcohol 53(6): 546-552
Bolla, K.I. 1996: Neuropsychological evaluation for detecting alterations in the central nervous system after chemical exposure. Regulatory Toxicology and Pharmacology: Rtp 24(1 Part 2): S48-S51
Turtas, S.; Tondi, M.; Tola, G.; Sehrbundt Viale, E.; Martinez, P.L. 1993: Neuropsychological evaluation in a series of 17 cases operated on for craniosynostosis. Acta Neurochirurgica 120(3-4): 123-125
Loring, D.W. 1997: Neuropsychological evaluation in epilepsy surgery. Epilepsia 38(Suppl): S18-S23
García-Pérez, A.; Sierrasesumaga, L.; Narbona-García, J.; Calvo-Manuel, F.; Aguirre-Ventalló, M. 1994: Neuropsychological evaluation of children with intracranial tumors: Impact of treatment modalities. Medical and Pediatric Oncology 23(2): 116-123
Janzen, L.A.; Nanson, J.L.; Block, G.W. 1995: Neuropsychological evaluation of preschoolers with fetal alcohol syndrome. Neurotoxicology and Teratology 17(3): 273-279
Làdavas, E.; Pavani, F. 1998: Neuropsychological evidence of the functional integration of visual, auditory and proprioceptive spatial maps. Neuroreport 9(6): 1195-1200
Censits, D.M.; Ragland, J.D.; Gur, R.C.; Gur, R.E. 1997: Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: A longitudinal study. Schizophrenia Research 24(3): 289-298
Almkvist, O. 1996: Neuropsychological features of early Alzheimer's disease: Preclinical and clinical stages. Acta Neurologica Scandinavica. Supplementum 165: 63-71
Swearer, J.M.; O'Donnell, B.F.; Drachman, D.A.; Woodward, B.M. 1992: Neuropsychological features of familial Alzheimer's disease. Annals of Neurology 32(5): 687-694
Reinvang, I.; Borchgrevink, H.M.; Aaserud, O.; Lie, V.; Malt, U.F.; Nakstad, P.; Larsson, P.G.; Gjerstad, L. 1994: Neuropsychological findings in a non-clinical sample of workers exposed to solvents. Journal of Neurology Neurosurgery and Psychiatry 57(5): 614-616
Kazui, H.; Tanabe, H.; Nakagawa, Y.; Ikeda, M.; Ikejiri, Y.; Shiraishi, J.; Hirano, S.; Kato, A.; Yoshimine, T.; Hayakawa, T. 1993: Neuropsychological findings of functional cortical mapping in patients with brain tumors. No to Shinkei 45(7): 641-648
Marcheschi, M.; Bargagna, S.; Dinetti, D.; Giachetti, C.; Millepiedi, S.; Nencioli, R. 1997: Neuropsychological follow-up for pre-school children with early-treated congenital hypothyroidism: A proposal for a methodological revision. Giornale di Neuropsichiatria dell'Eta Evolutiva 17(3): 139-151
Joy, P.; Roberts, C.; North, K.; de Silva, M. 1995: Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Developmental Medicine and Child Neurology 37(10): 906-914
Taylor, S.F.; Goldman, R.S.; Tandon, R.; Shipley, J.E. 1992: Neuropsychological function and REM sleep in schizophrenic patients. Biological Psychiatry 32(6): 529-538
Porterfield, T.; Cook, M.; Deary, I.J.; Ebmeier, K.P. 1997: Neuropsychological function and diurnal variation in depression. Journal of Clinical and Experimental Neuropsychology 19(6): 906-913
Zlotnick, C.; Agnew, J. 1997: Neuropsychological function and psychosocial status of alcohol rehabilitation program residents. Addictive Behaviors 22(2): 183-194
Iwasaki, Y.; Kinoshita, M.; Ikeda, K.; Shiojima, T.; Kurihara, T. 1993: Neuropsychological function before and after plasma exchange in myasthenia gravis. Journal of the Neurological Sciences 114(2): 223-226
Glosser, G.; McManus, P.; Munzenrider, J.; Austin-Seymour, M.; Fullerton, B.; Adams, J.; Urie, M.M. 1997: Neuropsychological function in adults after high dose fractionated radiation therapy of skull base tumors. International Journal of Radiation Oncology Biology Physics 38(2): 231-239
Seidman, L.J.; Biederman, J.; Weber, W.; Hatch, M.; Faraone, S.V. 1998: Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biological Psychiatry 44(4): 260-268
Grunseit, A.C.; Perdices, M.; Dunbar, N.; Cooper, D.A. 1994: Neuropsychological function in asymptomatic HIV-1 infection: methodological issues. Journal of Clinical and Experimental Neuropsychology 16(6): 898-910
Swirsky-Sacchetti, T.; Gorton, G.; Samuel, S.; Sobel, R.; Genetta-Wadley, A.; Burleigh, B. 1993: Neuropsychological function in borderline personality disorder. Journal of Clinical Psychology 49(3): 385-396
Seidman, L.J.; Caplan, B.B.; Tolomiczenko, G.S.; Turner, W.M.; Penk, W.E.; Schutt, R.K.; Goldfinger, S.M. 1997: Neuropsychological function in homeless mentally ill individuals. Journal of Nervous and Mental Disease 185(1): 3-12
McKay, A.P.; Tarbuck, A.F.; Shapleske, J.; McKenna, P.J. 1995: Neuropsychological function in manic-depressive psychosis. Evidence for persistent deficits in patients with chronic, severe illness. British Journal of Psychiatry: the Journal of Mental Science 167(1): 51-57
Redline, S.; Strauss, M.E.; Adams, N.; Winters, M.; Roebuck, T.; Spry, K.; Rosenberg, C.; Adams, K. 1997: Neuropsychological function in mild sleep-disordered breathing. Sleep 20(2): 160-167
Bornstein, R.A.; Starling, R.C.; Myerowitz, P.D.; Haas, G.J. 1995: Neuropsychological function in patients with end-stage heart failure before and after cardiac transplantation. Acta Neurologica Scandinavica 91(4): 260-265
Waterloo, K.; Ingebrigtsen, T.; Romner, B. 1997: Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochirurgica 139(1): 26-31; discussion 31-2
Phillips, N.A.; Mate-Kole, C.C.; Kirby, R.L. 1993: Neuropsychological function in peripheral vascular disease amputee patients. Archives of Physical Medicine and Rehabilitation 74(12): 1309-1314
Smith-Seemiller, L.; Lovell, M.R.; Franzen, M.D.; Smith, S.S.; Townsend, R.N. 1997: Neuropsychological function in restrained versus unrestrained motor vehicle occupants who suffer Closed Head Injury. Brain Injury 11(10): 735-742
Faraone, S.V.; Seidman, L.J.; Kremen, W.S.; Toomey, R.; Lyons, M.J.; Tsuang, M.T. 1996: Neuropsychological functioning among the elderly nonpsychotic relatives of schizophrenic patients. Schizophrenia Research 21(1): 27-31
Faraone, S.V.; Seidman, L.J.; Kremen, W.S.; Pepple, J.R.; Lyons, M.J.; Tsuang, M.T. 1995: Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a diagnostic efficiency analysis. Journal of Abnormal Psychology 104(2): 286-304
Macciocchi, S.N.; Barth, J.T.; Alves, W.; Rimel, R.W.; Jane, J.A. 1996: Neuropsychological functioning and recovery after mild head injury in collegiate athletes. Neurosurgery 39(3): 510-514
Hayward, L.B.; Mant, A.; Eyland, E.A.; Hewitt, H.; Pond, C.D.; Saunders, N.A. 1992: Neuropsychological functioning and sleep patterns in the elderly. Medical Journal of Australia 157(1): 51-52
Philpott, L.M.; Kopyov, O.V.; Lee, A.J.; Jacques, S.; Duma, C.M.; Caine, S.; Yang, M.; Eagle, K.S. 1997: Neuropsychological functioning following fetal striatal transplantation in Huntington's chorea: Three case presentations. Cell Transplantation 6(3): 203-212
Northam, E.; Bowden, S.; Anderson, V.; Court, J. 1992: Neuropsychological functioning in adolescents with diabetes. Journal of Clinical and Experimental Neuropsychology 14(6): 884-900
Massman, P.J.; Kreiter, K.T.; Jankovic, J.; Doody, R.S. 1996: Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology 46(3): 720-726
Eckardt, M.J.; Stapleton, J.M.; Rawlings, R.R.; Davis, E.Z.; Grodin, D.M. 1995: Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age. American Journal of Psychiatry 152(1): 53-59
Selby, M.J.; Azrin, R.L. 1998: Neuropsychological functioning in drug abusers. Drug and Alcohol Dependence 50(1): 39-45
Minshew, N.J.; Goldstein, G.; Muenz, L.R.; Payton, J.B. 1992: Neuropsychological functioning in nonmentally retarded autistic individuals. Journal of Clinical and Experimental Neuropsychology 14(5): 749-761
Cannon, T.D.; Zorrilla, L.E.; Shtasel, D.; Gur, R.E.; Gur, R.C.; Marco, E.J.; Moberg, P.; Price, R.A. 1994: Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Archives of General Psychiatry 51(8): 651-661
Ozkaragoz, T.; Satz, P.; Noble, E.P. 1997: Neuropsychological functioning in sons of active alcoholic, recovering alcoholic, and social drinking fathers. Alcohol 14(1): 31-37
Botez-Marquard, T.; Léveillé, J.; Botez, M.I. 1994: Neuropsychological functioning in unilateral cerebellar damage. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 21(4): 353-357
Al'tman, Y.A. 1995: Neuropsychological hypothesis of the mechanisms of poetical inspiration. Zhurnal Vysshei Nervnoi Deyatel'nosti Imeni I P Pavlova 45(2): 227-241
Thomas, S.V.; Alexander, A.; Padmanabhan, V.; Sankara Sarma, P. 1998: Neuropsychological impairment and altered thyroid hormone levels in epilepsy. National Medical Journal of India 11(2): 62-65
Binder, J.; Albus, M.; Hubmann, W.; Scherer, J.; Sobizack, N.; Franz, U.; Mohr, F.; Hecht, S. 1998: Neuropsychological impairment and psychopathology in first-episode schizophrenic patients related to the early course of illness. European Archives of Psychiatry and Clinical Neuroscience 248(2): 70-77
Godfrey, H.P.; Bishara, S.N.; Partridge, F.M.; Knight, R.G. 1993: Neuropsychological impairment and return to work following severe closed head injury: implications for clinical management. New Zealand Medical Journal 106(960): 301-303
Amitai, Y.; Zlotogorski, Z.; Golan-Katzav, V.; Wexler, A.; Gross, D. 1998: Neuropsychological impairment from acute low-level exposure to carbon monoxide. Archives of Neurology 55(6): 845-848
Tröster, A.I.; Stalp, L.D.; Paolo, A.M.; Fields, J.A.; Koller, W.C. 1995: Neuropsychological impairment in Parkinson's disease with and without depression. Archives of Neurology 52(12): 1164-1169
Albus, M.; Hubmann, W.; Ehrenberg, C.; Forcht, U.; Mohr, F.; Sobizack, N.; Wahlheim, C.; Hecht, S. 1996: Neuropsychological impairment in first-episode and chronic schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience 246(5): 249-255
DeLuca, J.; Johnson, S.K.; Beldowicz, D.; Natelson, B.H. 1995: Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. Journal of Neurology Neurosurgery and Psychiatry 58(1): 38-43
Buchanan, R.W.; Strauss, M.E.; Kirkpatrick, B.; Holstein, C.; Breier, A.; Carpenter, W.T. 1994: Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry 51(10): 804-811
Deakin, J.F. 1994: Neuropsychological implications of brain changes in schizophrenia: an overview. Psychopathology 27(3-5): 251-254
Tupler, L.A.; Coffey, C.E.; Logue, P.E.; Djang, W.T.; Fagan, S.M. 1992: Neuropsychological importance of subcortical white matter hyperintensity. Archives of Neurology 49(12): 1248-1252
Valera Bestard, R.; Navarro Humanes, J.F. 1993: Neuropsychological intervention in a case of anomic aphasia. Psiquis 14(2): 51-54
Tei, H.; Soma, Y.; Maruyama, S. 1993: Neuropsychological investigation in multiple sclerosis. No to Shinkei 45(2): 133-137
Kotterba, S.; Rasche, K.; Widdig, W.; Duscha, C.; Blombach, S.; Schultze-Werninghaus, G.; Malin, J.P. 1998: Neuropsychological investigations and event-related potentials in obstructive sleep apnea syndrome before and during CPAP-therapy. Journal of the Neurological Sciences 159(1): 45-50
Shutty, M.S.; Briscoe, L.; Sautter, S.; Leadbetter, R.A. 1993: Neuropsychological manifestations of hyponatremia in chronic schizophrenic patients with the syndrome of psychosis, intermittent hyponatremia and polydipsia (PIP). Schizophrenia Research 10(2): 125-130
Sartori, G.; Prior, M.; Valenti, N. 1993: Neuropsychological markers in asymptomatic HIV+ subject. Archivio di Psicologia Neurologia e Psichiatria 54(2): 293-304
Kurth, S.M.; Bigler, E.D.; Blatter, D.D. 1994: Neuropsychological outcome and quantitative image analysis of acute haemorrhage in traumatic brain injury: preliminary findings. Brain Injury 8(6): 489-500
Kunishio, K.; Matsumoto, Y.; Kawada, S.; Miyoshi, Y.; Matsuhisa, T.; Moriyama, E.; Norikane, H.; Tanaka, R. 1993: Neuropsychological outcome and social recovery of head-injured patients. Neurologia Medico-Chirurgica 33(12): 824-829
García-Peréz, A.; Narbona-García, J.; Sierrasesúmaga, L.; Aguirre-Ventalló, M.; Calvo-Manuel, F. 1993: Neuropsychological outcome of children after radiotherapy for intracranial tumours. Developmental Medicine and Child Neurology 35(2): 139-148
Kunishio, K.; Kawada, S.; Miyoshi, Y.; Mandai, S.; Matsuhisa, T.; Moriyama, E.; Matsumoto, Y.; Tanaka, R. 1993: Neuropsychological outcome of head injury in children. No Shinkei Geka. Neurological Surgery 21(10): 915-920
De Santis, A.; Laiacona, M.; Barbarotto, R.; De Divitiis, O.; Migliore, M.; Capitani, E. 1998: Neuropsychological outcome of operated cerebral aneurysms: Prognostic factors on 148 patients. Acta Neurologica Scandinavica 97(6): 393-397
Cochrane, H.C.; Marson, A.G.; Baker, G.A.; Chadwick, D.W. 1998: Neuropsychological outcomes in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards. Epilepsia 39(10): 1088-1097
Shapiro, E.G.; Lockman, L.A.; Balthazor, M.; Krivit, W. 1995: Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. Journal of Inherited Metabolic Disease 18(4): 413-429
Pillon, B.; Gouider-Khouja, N.; Deweer, B.; Vidailhet, M.; Malapani, C.; Dubois, B.; Agid, Y. 1995: Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy. Journal of Neurology Neurosurgery and Psychiatry 58(2): 174-179
Price, B.H.; Gurvit, H.; Weintraub, S.; Geula, C.; Leimkuhler, E.; Mesulam, M. 1993: Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Archives of Neurology 50(9): 931-937
Resnick, A.; Perry, W.; Parry, B.; Mostofi, N.; Udell, C. 1998: Neuropsychological performance across the menstrual cycle in women with and without premenstrual dysphoric disorder. Psychiatry Research 77(3): 147-158
Daniell, W.; Barnhart, S.; Demers, P.; Costa, L.G.; Eaton, D.L.; Miller, M.; Rosenstock, L. 1992: Neuropsychological performance among agricultural pesticide applicators. Environmental Research 59(1): 217-228
Podraza, A.M.; Bornstein, R.A.; Whitacre, C.C.; Para, M.F.; Fass, R.J.; Rice, R.R.; Nasrallah, H.A. 1994: Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. Journal of Clinical and Experimental Neuropsychology 16(5): 777-783
Eller, P.M. 1993: Neuropsychological performance and solvent exposure among car body repair shop workers. British Journal of Industrial Medicine 50(12): 1126-1127
Ellis, T.E.; Berg, R.A.; Franzen, M.D. 1992: Neuropsychological performance and suicidal behavior in adult psychiatric inpatients. Perceptual and Motor Skills 75(2): 639-647
Grassi, M.P.; Perin, C.; Clerici, F.; Zocchetti, C.; Cargnel, A.; Mangoni, A. 1993: Neuropsychological performance in HIV-1-infected drug abusers. Acta Neurologica Scandinavica 88(2): 119-122
Seidman, L.J.; Pepple, J.R.; Faraone, S.V.; Kremen, W.S.; Green, A.I.; Brown, W.A.; Tsuang, M.T. 1993: Neuropsychological performance in chronic schizophrenia in response to neuroleptic dose reduction. Biological Psychiatry 33(8-9): 575-584
Sommerfelt, K.; Markestad, T.; Ellertsen, B. 1998: Neuropsychological performance in low birth weight preschoolers: A population-based, controlled study. European Journal of Pediatrics 157(1): 53-58
Bornstein, R.A.; Nasrallah, H.A.; Para, M.F.; Whitacre, C.C.; Rosenberger, P.; Fass, R.J. 1993: Neuropsychological performance in symptomatic and asymptomatic HIV infection. Aids 7(4): 519-524
Beatty, W.W.; Katzung, V.M.; Moreland, V.J.; Nixon, S.J. 1995: Neuropsychological performance of recently abstinent alcoholics and cocaine abusers. Drug and Alcohol Dependence 37(3): 247-253
Waldstein, S.R.; Ryan, C.M.; Polefrone, J.M.; Manuck, S.B. 1994: Neuropsychological performance of young men who vary in familial risk for hypertension. Psychosomatic Medicine 56(5): 449-456
Giancola, P.R.; Zeichner, A. 1994: Neuropsychological performance on tests of frontal-lobe functioning and aggressive behavior in men. Journal of Abnormal Psychology 103(4): 832-835
Esmonde, T.; Giles, E.; Gibson, M.; Hodges, J.R. 1996: Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. Journal of Neurology 243(9): 638-643
Mahieux, F.; Fénelon, G.; Flahault, A.; Manifacier, M.J.; Michelet, D.; Boller, F. 1998: Neuropsychological prediction of dementia in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 64(2): 178-183
Goldman, R.S.; Axelrod, B.N.; Tandon, R.; Ribeiro, S.C.; Craig, K.; Berent, S. 1993: Neuropsychological prediction of treatment efficacy and one-year outcome in schizophrenia. Psychopathology 26(3-4): 122-126
Kern, R.S.; Green, M.F.; Satz, P. 1992: Neuropsychological predictors of skills training for chronic psychiatric patients. Psychiatry Research 43(3): 223-230
Kaitaro, T.; Koskinen, S.; Kaipio, M.L. 1995: Neuropsychological problems in everyday life: a 5-year follow-up study of young severely closed-head-injured patients. Brain Injury 9(7): 713-727
Kasper, M.E.; Harrell, E.H.; Jones, W.B.; Krusz, J.C. 1998: Neuropsychological profile associated with silicone-gel breast implants. Journal Of Nutritional and Environmental Medicine (abingdon). 8(1): 7-17
Seltzer, J.; Conrad, C.; Cassens, G. 1997: Neuropsychological profiles in schizophrenia: paranoid versus undifferentiated distinctions. Schizophrenia Research 23(2): 131-138
Mazzocco, M.M.; Holden, J.J. 1996: Neuropsychological profiles of three sisters homozygous for the fragile X premutation. American Journal of Medical Genetics 64(2): 323-328
Silverstein, M.L.; Harrow, M.; Bryson, G.J. 1994: Neuropsychological prognosis and clinical recovery. Psychiatry Research 52(3): 265-272
Bowen, M.; Marks, M.P.; Steinberg, G.K. 1998: Neuropsychological recovery from childhood moyamoya disease. Brain and Development 20(2): 119-123
Pradat Diehl, P.; Bergego, C. 1994: Neuropsychological rehabilitation after stroke. Circulation et Metabolisme du Cerveau 11(2): 129-134
Cicerone, K.D.; Smith, L.C.; Ellmo, W.; Mangel, H.R.; Nelson, P.; Chase, R.F.; Kalmar, K. 1996: Neuropsychological rehabilitation of mild traumatic brain injury. Brain Injury 10(4): 277-286
Franzen, M.D.; Harris, C.V. 1993: Neuropsychological rehabilitation: application of a modified multiple baseline design. Brain Injury 7(6): 525-534
Honegger, J.; Barocka, A.; Sadri, B.; Fahlbusch, R. 1998: Neuropsychological results of craniopharyngioma surgery in adults: A prospective study. Surgical Neurology 50(1): 19-28; discussion 28-9
Zav'ialov, A.V.; Sever'ianova, L.A.; Plotnikov, V.V.; Plotnikov, D.V. 1998: Neuropsychological risk factors of ischemic heart disease. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1998(5): 11-16
Kremen, W.S.; Faraone, S.V.; Seidman, L.J.; Pepple, J.R.; Tsuang, M.T. 1998: Neuropsychological risk indicators for schizophrenia: A preliminary study of female relatives of schizophrenic and bipolar probands. Psychiatry Research 79(3): 227-240
Kremen, W.S.; Seidman, L.J.; Pepple, J.R.; Lyons, M.J.; Tsuang, M.T.; Faraone, S.V. 1994: Neuropsychological risk indicators for schizophrenia: a review of family studies. Schizophrenia Bulletin 20(1): 103-119
Galynker, I.I.; Harvey, P.D. 1992: Neuropsychological screening in the psychiatric emergency room. Comprehensive Psychiatry 33(5): 291-295
Yang, T.F.; Wong, T.T.; Cheng, L.Y.; Chang, T.K.; Hsu, T.C.; Chen, S.J.; Chuang, T.Y. 1997: Neuropsychological sequelae after treatment for medulloblastoma in childhood--the Taiwan experience. Child's Nervous System: Chns: Official Journal of the International Society for Pediatric Neurosurgery 13(2): 77-80; Discussion 81
Roine, R.O.; Kajaste, S.; Kaste, M. 1993: Neuropsychological sequelae of cardiac arrest. JAMA 269(2): 237-242
Leathem, J.M.; Body, C.M. 1997: Neuropsychological sequelae of head injury in a New Zealand adolescent sample. Brain Injury 11(8): 565-575
Kramer, J.H.; Crowe, A.B.; Larson, D.A.; Sneed, P.K.; Gutin, P.H.; McDermott, M.W.; Prados, M.D. 1997: Neuropsychological sequelae of medulloblastoma in adults. International Journal of Radiation Oncology Biology Physics 38(1): 21-26
Reidy, T.J.; Bolter, J.F.; Cone, J.E. 1994: Neuropsychological sequelae of methyl bromide: A case study. Brain Injury 8(1): 83-93
Moore, B.D.; Slopis, J.M.; Schomer, D.; Jackson, E.F.; Levy, B.M. 1996: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46(6): 1660-1668
Galderisi, S.; Mucci, A.; Catapano, F.; D'Amato, A.C.; Maj, M. 1995: Neuropsychological slowness in obsessive-compulsive patients. Is it confined to tests involving the fronto-subcortical systems?. British Journal of Psychiatry: the Journal of Mental Science 167(3): 394-398
Schuerholz, L.J.; Baumgardner, T.L.; Singer, H.S.; Reiss, A.L.; Denckla, M.B. 1996: Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder. Neurology 46(4): 958-965
Milner, A.D. 1998: Neuropsychological studies of perception and visuomotor control. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 353(1373): 1375-1384
Francione, S.; Priano, F.; Ferrari, A.; Bottini, G.; Rodriguez, G.; Rosadini, G.; Munari, C. 1997: Neuropsychological study during video-EEG recording of successive partial seizures of right temporo-central origin. Italian Journal of Neurological Sciences 18(4): 209-214
Lenti, C.; Campetella, S.; Narcisi, R.; Dieci, M.; Siragusa, V.; Weber, G.; Chiumello, G. 1992: Neuropsychological study in children treated for congenital hypothyroidism from early life. Giornale di Neuropsichiatria dell'Eta Evolutiva 12(4): 335-339
Mamaichuk, I.I. 1992: Neuropsychological study of gnostic processes in children with different forms of cerebral palsy. Zhurnal Nevropatologii i Psikhiatrii Imeni S S Korsakova 92(4): 42-47
Fisher, N.J.; Rourke, B.P.; Bieliauskas, L.; Giordani, B.; Berent, S.; Foster, N.L. 1996: Neuropsychological subgroups of patients with Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology 18(3): 349-370
Pliskin, N.H.; Capelli-Schellpfeffer, M.; Law, R.T.; Malina, A.C.; Kelley, K.M.; Lee, R.C. 1998: Neuropsychological symptom presentation after electrical injury. Journal of Trauma 44(4): 709-715
Hakkola, M.; Honkasalo, M.L.; Pulkkinen, P. 1996: Neuropsychological symptoms among tanker drivers exposed to gasoline. Occupational Medicine 46(2): 125-130
Hakkola, M. 1994: Neuropsychological symptoms among tanker drivers with exposure to solvents. Occupational Medicine 44(5): 243-246
Kataeva, N.G.; Krasik, E.D.; Komandenko, N.I. 1992: Neuropsychological syndromes in hereditary neuromuscular pathology. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(4): 31-35
Jin, L.; Zhang, W.; Ye, H. 1994: Neuropsychological test in brain atrophy patient. Hunan Yike Daxue Xuebao 19(5): 445-448
Reite, M.; Cullum, C.M.; Stocker, J.; Teale, P.; Kozora, E. 1993: Neuropsychological test performance and MEG-based brain lateralization: Sex differences. Brain Research Bulletin 32(3): 325-328
Bartel, P.R.; Lotz, B.P. 1995: Neuropsychological test performance and affect in myasthenia gravis. Acta Neurologica Scandinavica 91(4): 266-270
Elias, M.F.; D'Agostino, R.B.; Elias, P.K.; Wolf, P.A. 1995: Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. Experimental Aging Research 21(4): 369-391
Steenhuis, R.E.; Ostbye, T. 1995: Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). Journal of Clinical and Experimental Neuropsychology 17(5): 773-785
Elfgren, C.; Brun, A.; Gustafson, L.; Johanson, A.; Minthon, L.; Passant, U.; Risberg, J. 1994: Neuropsychological tests as discriminators between dementia of Alzheimer type and frontotemporal dementia. International Journal of Geriatric Psychiatry 9(8): 635-642
Reidy, T.J.; Bolter, J.F. 1994: Neuropsychological toxicology of methylene diphenyl diisocyanate: a report of five cases. Brain Injury 8(3): 285-294
Lucas, M.D.; Sonnenberg, B.R. 1996: Neuropsychological trends in the parkinsonism-plus syndrome: a pilot study. Journal of Clinical and Experimental Neuropsychology 18(1): 88-97
Pradat Diehl, P.; Marchal, F.; Tessier, C.; Lauriot Prevost, M.C.; Arnaud, A.; Mazevet, D.; Perrigot, M. 1997: Neuropsychological troubles and recovery of work after stroke. Annales de Readaptation et de Medecine Physique 40(2): 83-87
Marra, C.; Polito, A.; Verrienti, D.; Silveri, M.C. 1997: Neuropsychological variables predicting rate of cognitive decline in Alzheimer's disease. Preliminary data. Archivio di Psicologia Neurologia e Psichiatria 58(4): 414-436
Michélsen, H.; Lundberg, I. 1996: Neuropsychological verbal tests may lack "hold" properties in occupational studies of neurotoxic effects. Occupational and Environmental Medicine 53(7): 478-483
Weglage, J.; Demsky, A.; Pietsch, M.; Kurlemann, G. 1997: Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures. Developmental Medicine and Child Neurology 39(10): 646-651
Scott, R.; Gregory, R.; Hines, N.; Carroll, C.; Hyman, N.; Papanasstasiou, V.; Leather, C.; Rowe, J.; Silburn, P.; Aziz, T. 1998: Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. a consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain: a Journal of Neurology 121: 659-675
Stedman, T.J.; Clair, A.L. 1998: Neuropsychological, neurological and symptom correlates of impaired olfactory identification in schizophrenia. Schizophrenia Research 32(1): 23-30
Brewer, W.J.; Edwards, J.; Anderson, V.; Robinson, T.; Pantelis, C. 1996: Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biological Psychiatry 40(10): 1021-1031
Bremer, B.A.; Wert, K.W.; Durica, A.L.; Weaver, A. 1997: Neuropsychological, physical, and psychosocial functioning of individuals with end-stage renal disease. Annals Of Behavioral Medicine. : 348-352
Starkstein, S.E.; Sabe, L.; Vazquez, S.; Teson, A.; Petracca, G.; Chemerinski, E.; Di Lorenzo, G.; Leiguarda, R. 1996: Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 27(3): 408-414
Starkstein, S.E.; Sabe, L.; Vázquez, S.; Di Lorenzo, G.; Martínez, A.; Petracca, G.; Tesón, A.; Chemerinski, E.; Leiguarda, R. 1997: Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 63(1): 66-73
Satz, P.; Zaucha, K.; Forney, D.L.; McCleary, C.; Asarnow, R.F.; Light, R.; Levin, H.; Kelly, D.; Bergsneider, M.; Hovda, D.; Martin, N.; Caron, M.J.; Namerow, N.; Becker, D. 1998: Neuropsychological, psychosocial and vocational correlates of the Glasgow Outcome Scale at 6 months post-injury: a study of moderate to severe traumatic brain injury patients. Brain Injury 12(7): 555-567
Calev, A. 1994: Neuropsychology and ECT: past and future research trends. Psychopharmacology Bulletin 30(3): 461-469
Tiersky, L.A.; Johnson, S.K.; Lange, G.; Natelson, B.H.; DeLuca, J. 1997: Neuropsychology of chronic fatigue syndrome: a critical review. Journal of Clinical and Experimental Neuropsychology 19(4): 560-586
Lechevalier, B.; Platel, H.; Eustache, F. 1995: Neuropsychology of musical identification. Revue Neurologique (Paris) 151(8-9): 505-510
Fleming, A.S.; Walsh, C. 1994: Neuropsychology of maternal behavior in the rat: c-fos expression during mother-litter interactions. Psychoneuroendocrinology 19(5-7): 429-443
Greene, J.D.; Miles, K.; Hodges, J.R. 1996: Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type. Journal of Neurology 243(2): 175-190
Sanz, D.L.T.rre, J.C.; Junque Plaja, C.; Perez Rios, M. 1993: Neuropsychology of schizophrenia. Psiquis 14(1): 23-37
Zec, R.F.; Kraepelin, E. 1995: Neuropsychology of schizophrenia according to Kraepelin: Disorders of volition and executive functioning. European Archives of Psychiatry and Clinical Neuroscience 245(4-5): 216-223
Sabatino, M.; Di Nuovo, S.; Sardo, P.; Abbate, C.S.; La Grutta, V. 1996: Neuropsychology of selective attention and magnetic cortical stimulation. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 21(2-3): 83-89
McMillan, T.M.; Jacobson, R.R.; Gross, M. 1997: Neuropsychology of thallium poisoning. Journal of Neurology Neurosurgery and Psychiatry 63(2): 247-250
Artiola i Fortuny, L.; Mullaney, H.A. 1997: Neuropsychology with Spanish speakers: language use and proficiency issues for test development. Journal of Clinical and Experimental Neuropsychology 19(4): 615-622
Heyer, E.J.; Adams, D.C.; Solomon, R.A.; Todd, G.J.; Quest, D.O.; McMahon, D.J.; Steneck, S.D.; Choudhri, T.F.; Connolly, E.S. 1998: Neuropsychometric changes in patients after carotid endarterectomy. Stroke 29(6): 1110-1115
Gregor, A.; Cull, A.; Traynor, E.; Stewart, M.; Lander, F.; Love, S. 1996: Neuropsychometric evaluation of long-term survivors of adult brain tumours: Relationship with tumour and treatment parameters. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 41(1): 55-59
Coccaro, E.F.; Kavoussi, R.J. 1994: Neuropsychopharmacologic challenge in biological psychiatry. Clinical Chemistry 40(2): 319-327
Singh, H.K.; Dhawan, B.N. 1997: Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian Journal of Pharmacology 29(5): S359-S365
Solanto, M.V. 1998: Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behavioural Brain Research 94(1): 127-152
Simiand, J.; Keane, P.E.; Barnouin, M.C.; Keane, M.; Soubrié, P.; Le Fur, G. 1993: Neuropsychopharmacological profile in rodents of SR 57746A, a new, potent 5-HT1A receptor agonist. Fundamental and Clinical Pharmacology 7(8): 413-427
Skuza, G.; Rogóz, Z.; Wieczorek, A. 1997: Neuropsychopharmacological profile of remoxipride in comparison with clozapine. Polish Journal of Pharmacology 49(1): 5-15
Meyer, R.E. 1996: Neuropsychopharmacology: are we ready for a paradigm shift?. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 14(3): 169-179
Derouesne, C.; Renault, B.; Gueguen, B.; Van-Der-Linden, M.; Lacomblez, L.; Homeyer, P.; Ouss, L.; Neuman, E.; Malbezin, M.; Barrandon, S.; Guez, D. 1997: Neuropsychophysiological evaluation of three doses of S 12024-2 in mild-to-moderate Alzheimer's disease. Clinical Drug Investigation 14(4): 301-306
Hendren, R.L.; Hodde-Vargas, J.; Yeo, R.A.; Vargas, L.A.; Brooks, W.M.; Ford, C. 1995: Neuropsychophysiological study of children at risk for schizophrenia: a preliminary report. Journal of the American Academy of Child and Adolescent Psychiatry 34(10): 1284-1291
Ponomarenko, A.G. 1992: Neuroptera (Insecta) from the Lower Cretaceous of Transbaikalia. Paleontologiceskij Zurnal (3): 43-50
Martins-Neto, Rafael-Gioia 1992: Neuroptera (Insecta, Planipennia) from the Santana formation (Lower Cretaceous), Araripe Basin, Northeastern Brazil: VII. Palaeoleontinae, a new subfamily of Myrmeleontidae and description of new Neuropteran taxa. Revista Brasileira de Entomologia 36(4): 803-815
Devetak, D. 1998: Neuroptera in different habitats is Istria and Quarnero (NW Balkan). Acta Zoologica Fennica 1998(209): 95-98
Mirmoayedi, A. 1998: Neuroptera of Iran. Acta Zoologica Fennica 1998(209): 163-165
Mcewen, P.; Oswald, J. 1998: Neuroptera on the Internet. Acta Zoologica Fennica 1998(209): 151-152
Czechowska, W. 1994: Neuropterans (Neuropteroidea: Raphidioptera, Planipennia) of the canopy layer in pine forests. Fragmenta Faunistica 36(19-25): 459-467
Boppana, S.B.; Fowler, K.B.; Vaid, Y.; Hedlund, G.; Stagno, S.; Britt, W.J.; Pass, R.F. 1997: Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 99(3): 409-414
Shinomiya, K.; Komori, H.; Matsuoka, T.; Mutoh, N.; Furuya, K. 1994: Neuroradiologic and electrophysiologic assessment of cervical spondylotic amyotrophy. Spine 19(1): 21-25
Caparros-Lefebvre, D.; Pruvo, J.P.; Rémy, M.; Wallaert, B.; Petit, H. 1995: Neuroradiologic aspects of Chester-Erdheim disease. Ajnr. American Journal of Neuroradiology 16(4): 735-740
Wolpert, S.M.; Bruckmann, H.; Greelee, R.; Wechsler, L.; Pessin, M.S.; Del Zoppo, G.J.; Group, T.R.P.A.ute Stroke Study 1993: Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR (American Journal of Neuroradiology) 14(1): 3-13
Georgy, B.A.; Snow, R.D.; Brogdon, B.G.; Wertelecki, W. 1998: Neuroradiologic findings in Marinesco-Sjögren syndrome. Ajnr. American Journal of Neuroradiology 19(2): 281-283
Valanne, L.; Ketonen, L.; Majander, A.; Suomalainen, A.; Pihko, H. 1998: Neuroradiologic findings in children with mitochondrial disorders. Ajnr. American Journal of Neuroradiology 19(2): 369-377
Provenzale, J.M.; Barboriak, D.P.; Sims, K. 1995: Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease. Ajnr. American Journal of Neuroradiology 16(4 Suppl): 809-813
Landero-Ruiz, A.; Madrazo, I. 1996: Neuroradiologic findings in glutaric aminoaciduria type I: Report of two cases. Revista Medica del Instituto Mexicano del Seguro Social 34(3): 195-199
Provenzale, J.M.; Allen, N.B. 1996: Neuroradiologic findings in polyarteritis nodosa. Ajnr. American Journal of Neuroradiology 17(6): 1119-1126
Leuzzi, V.; Gualdi, G.F.; Fabbrizi, F.; Trasimeni, G.; Di Biasi, C.; Antonozzi, I. 1993: Neuroradiological (MRI) abnormalities in phenylketonuric subjects: clinical and biochemical correlations. Neuropediatrics 24(6): 302-306
Kohlschütter, A. 1994: Neuroradiological and neurophysiological indices for neurometabolic disorders. European Journal of Pediatrics 153(7 Suppl 1): S90-S93
Ito, J.; Saijo, H.; Araki, A.; Tanaka, H.; Tasaki, T.; Cho, K.; Miyamoto, A. 1997: Neuroradiological assessment of visuoperceptual disturbance in children with spina bifida and hydrocephalus. Developmental Medicine and Child Neurology 39(6): 385-392
Jansen, O.; Heiland, S.; Schellinger, P. 1998: Neuroradiological diagnosis in acute ischemic stroke. Value of modern techniques. Nervenarzt 69(6): 465-471
Nakstad, P.H.; Bakke, S.J.; Ormåsen, E.; Lund, G.; Midtflå, V. 1994: Neuroradiological embolization. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(25): 2956-2959
Sue, C.M.; Crimmins, D.S.; Soo, Y.S.; Pamphlett, R.; Presgrave, C.M.; Kotsimbos, N.; Jean-Francois, M.J.; Byrne, E.; Morris, J.G. 1998: Neuroradiological features of six kindreds with MELAS tRNA(Leu) A2343G point mutation: implications for pathogenesis. Journal of Neurology Neurosurgery and Psychiatry 65(2): 233-240
Nagasawa, H.; Yamaguchi, S.; Suzuki, Y.; Kobayashi, M.; Wada, Y.; Shikura, K.; Shimao, S.; Okada, T.; Orii, T. 1992: Neuroradiological findings in glutaric aciduria type I: Report of four Japanese patients. Acta Paediatrica Japonica: Overseas Edition 34(4): 409-415
Becker, T.; Hofmann, E.; Knoche, M.; Lanczik, M. 1993: Neuroradiological findings in post partum psychiatric disorder. European Psychiatry 8(2): 105-107
Hirvasniemi, A.; Karumo, J. 1994: Neuroradiological findings in the northern epilepsy syndrome. Acta Neurologica Scandinavica 90(6): 388-393
Maytal, J.; Novak, G.P.; Knobler, S.B.; Schaul, N. 1993: Neuroradiological manifestations of focal polymorphic delta activity in children. Archives of Neurology 50(2): 181-184
Tamayo, M.L.; Maldonado, C.; Plaza, S.L.; Alvira, G.M.; Tamayo, G.E.; Zambrano, M.; Frias, J.L.; Bernal, J.E. 1996: Neuroradiology and clinical aspects of Usher syndrome. Clinical Genetics 50(3): 126-132
Wolpert, S.M. 1995: Neuroradiology in Boston: historical beginnings. AJNR. American Journal of Neuroradiology 16(5): 1093-1098
Ginsberg, L.E.; Leeds, N.E. 1995: Neuroradiology of leukemia. Ajr. American Journal of Roentgenology 165(3): 525-534
Innis, R.B. 1992: Neuroreceptor imaging with SPECT. Journal of Clinical Psychiatry 53 Suppl: 29-34
Brett, P.M.; Curtis, D.; Robertson, M.M.; Gurling, H.M. 1997: Neuroreceptor subunit genes and the genetic susceptibility to Gilles de la Tourette syndrome. Biological Psychiatry 42(10): 941-947
Sandler, A.D.; Schlegel, J.F.; DeSautel, M.G.; Maher, J.W. 1993: Neuroregulation of a chemosensitive afferent system in the canine distal esophagus. Journal of Surgical Research 55(4): 364-371
Arvat, E.; Bellone, J.; Procopio, M.; Grottoli, S.; Maccario, M.; Camanni, F.; Ghigo, E. 1996: Neuroregulation of growth hormone secretion in man. Developmental Brain Dysfunction 9(2-3): 93-99
Widdicombe, J.G. 1996: Neuroregulation of the nose and bronchi. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 26(Suppl): 32-35
Moore, D.P.; Lee, M.Y.; Macciocchi, S.N. 1997: Neurorehabilitation outcome in moyamoya disease. Archives of Physical Medicine and Rehabilitation 78(6): 672-675
Li, J.B.; Li, M.Y. 1993: Neuroretinal rim area in early glaucoma. Chinese Medical Journal (English Edition) 106(3): 191-195
García-Arumí, J.; Salvador, F.; Corcostegui, B.; Mateo, C. 1994: Neuroretinitis associated with melanocytoma of the optic disk. Retina 14(2): 173-176
Maniker, A.H.; Cho, E.S.; Schulder, M. 1997: Neurosarcoid infiltration of the ventricular catheter causing shunt failure: A case report. Surgical Neurology 48(5): 527-529
Briner, V.A.; Muller, A.; Gebbers, J.O. 1998: Neurosarcoidosis. Schweizerische Medizinische Wochenschrift 128(21): 799-810
Bona, J.R.; Fackler, S.M.; Fendley, M.J.; Nemeroff, C.B. 1998: Neurosarcoidosis as a cause of refractory psychosis: a complicated case report. American Journal of Psychiatry 155(8): 1106-1108
Yoshida, T.; Tanaka, M.; Okamoto, K.; Hirai, S. 1996: Neurosarcoidosis following augmentation mammoplasty with silicone. Neurological Research 18(4): 319-320
Ng, K.L.; McDermott, N.; Romanowski, C.A.; Jackson, A. 1995: Neurosarcoidosis masquerading as glioma of the optic chiasm in a child. Postgraduate Medical Journal 71(835): 265-268
Stübgen, J.P. 1995: Neurosarcoidosis presenting as a retroclival mass. Surgical Neurology 43(1): 85
Gizzi, M.S.; Lidov, M.; Rosenbaum, D. 1993: Neurosarcoidosis presenting as a tumour of the basal ganglia and brainstem: sequential MRI. Neurological Research 15(2): 93-96
Chaix, Y.; Grouteau, E.; Sevely, A.; Boetto, S.; Delisle, M.B.; Carriere, J.P. 1997: Pseudotumor forms of neurosarcoidosis in children. Diagnostic difficulties and therapeutic management. Revue Neurologique (Paris) 153(12): 771-774
Hanamitsu, M. 1996: Neurosarcoidosis with bilateral facial palsies. A case report. Jibi Inkoka Tokeibu Geka 68(13): 1055-1058
Sharma, O.P. 1997: Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 112(1): 220-228
Shail, E.; Siqueira, E.B.; Haider, A.; Halim, M. 1994: Neuroschistosomiasis myelopathy: case report. British Journal of Neurosurgery 8(2): 239-242
Hoebel, B.G. 1997: Neuroscience and appetitive behavior research: 25 years. Appetite 29(2): 119-133